KR100314366B1 - Antiferroelectric Liquid Crystal Display Device and Antiferroelectric compounds and Compositions for Use Therein - Google Patents
Antiferroelectric Liquid Crystal Display Device and Antiferroelectric compounds and Compositions for Use Therein Download PDFInfo
- Publication number
- KR100314366B1 KR100314366B1 KR1019990026751A KR19990026751A KR100314366B1 KR 100314366 B1 KR100314366 B1 KR 100314366B1 KR 1019990026751 A KR1019990026751 A KR 1019990026751A KR 19990026751 A KR19990026751 A KR 19990026751A KR 100314366 B1 KR100314366 B1 KR 100314366B1
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- formula
- less
- antiferroelectric
- ring
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 150
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 33
- 239000000203 mixture Substances 0.000 title claims description 25
- -1 mono-fluorophenyl Chemical group 0.000 claims abstract description 58
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 19
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 13
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 12
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 12
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims abstract description 7
- 125000004212 difluorophenyl group Chemical group 0.000 claims abstract description 7
- 125000000532 dioxanyl group Chemical group 0.000 claims abstract description 7
- 125000004076 pyridyl group Chemical group 0.000 claims abstract description 7
- 125000000714 pyrimidinyl group Chemical group 0.000 claims abstract description 7
- 229910002091 carbon monoxide Inorganic materials 0.000 claims abstract description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract 3
- 239000000463 material Substances 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 28
- 125000001153 fluoro group Chemical group F* 0.000 claims description 16
- 230000015572 biosynthetic process Effects 0.000 claims description 12
- 230000010287 polarization Effects 0.000 claims description 11
- 230000002269 spontaneous effect Effects 0.000 claims description 10
- 230000005540 biological transmission Effects 0.000 claims description 9
- 239000000758 substrate Substances 0.000 claims description 8
- 239000004990 Smectic liquid crystal Substances 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 230000001747 exhibiting effect Effects 0.000 claims description 3
- 230000000707 stereoselective effect Effects 0.000 claims description 3
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 2
- 230000004044 response Effects 0.000 claims description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims description 2
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims 1
- 229910052727 yttrium Inorganic materials 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 59
- XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 46
- 239000012071 phase Substances 0.000 description 40
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 36
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 34
- 239000000741 silica gel Substances 0.000 description 34
- 229910002027 silica gel Inorganic materials 0.000 description 34
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 33
- 238000003818 flash chromatography Methods 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- 239000007787 solid Substances 0.000 description 22
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 20
- 230000007704 transition Effects 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 229940093499 ethyl acetate Drugs 0.000 description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- 239000003990 capacitor Substances 0.000 description 12
- 238000002844 melting Methods 0.000 description 12
- 230000008018 melting Effects 0.000 description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 12
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 11
- SPWVRYZQLGQKGK-UHFFFAOYSA-N dichloromethane;hexane Chemical compound ClCCl.CCCCCC SPWVRYZQLGQKGK-UHFFFAOYSA-N 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 229960004132 diethyl ether Drugs 0.000 description 9
- QFOHBWFCKVYLES-UHFFFAOYSA-N n-butyl para-hydroxybenzoate Natural products CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 239000003921 oil Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 230000006399 behavior Effects 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 239000007858 starting material Substances 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 6
- 239000012267 brine Substances 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical class C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 6
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 5
- 239000012230 colorless oil Substances 0.000 description 5
- 229940125782 compound 2 Drugs 0.000 description 5
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 4
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 229910052709 silver Inorganic materials 0.000 description 4
- 239000004332 silver Substances 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- HPJGEESDHAUUQR-SKGSPYGFSA-N (2s)-2-[[(2s)-5-(diaminomethylideneamino)-2-[[(2s)-1-[(2s)-5-(diaminomethylideneamino)-2-[[(2s)-2-[[(2s)-3-naphthalen-2-yl-2-(3-pyridin-3-ylpropanoylamino)propanoyl]amino]-3-phenylpropanoyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]buta Chemical compound NC(=O)C[C@@H](C(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=C2C=CC=CC2=CC=1)NC(=O)CCC=1C=NC=CC=1)CC1=CC=CC=C1 HPJGEESDHAUUQR-SKGSPYGFSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229940126214 compound 3 Drugs 0.000 description 3
- 238000006880 cross-coupling reaction Methods 0.000 description 3
- LJQKCYFTNDAAPC-UHFFFAOYSA-N ethanol;ethyl acetate Chemical compound CCO.CCOC(C)=O LJQKCYFTNDAAPC-UHFFFAOYSA-N 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- HBEDNENASUYMPO-LJQANCHMSA-N n-hydroxy-4-[[(2r)-3-oxo-2-(thiophen-2-ylmethyl)-2,4-dihydroquinoxalin-1-yl]methyl]benzamide Chemical compound C1=CC(C(=O)NO)=CC=C1CN1C2=CC=CC=C2NC(=O)[C@H]1CC1=CC=CS1 HBEDNENASUYMPO-LJQANCHMSA-N 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- FIIFHPQHIUVXOD-GOSISDBHSA-N (2R)-4-tetradecoxybutan-2-ol Chemical compound C(CCCCCCCCCCCCC)OCC[C@@H](C)O FIIFHPQHIUVXOD-GOSISDBHSA-N 0.000 description 2
- SHAHPWSYJFYMRX-GDLCADMTSA-N (2S)-2-(4-{[(1R,2S)-2-hydroxycyclopentyl]methyl}phenyl)propanoic acid Chemical compound C1=CC([C@@H](C(O)=O)C)=CC=C1C[C@@H]1[C@@H](O)CCC1 SHAHPWSYJFYMRX-GDLCADMTSA-N 0.000 description 2
- LJIOTBMDLVHTBO-CUYJMHBOSA-N (2s)-2-amino-n-[(1r,2r)-1-cyano-2-[4-[4-(4-methylpiperazin-1-yl)sulfonylphenyl]phenyl]cyclopropyl]butanamide Chemical compound CC[C@H](N)C(=O)N[C@]1(C#N)C[C@@H]1C1=CC=C(C=2C=CC(=CC=2)S(=O)(=O)N2CCN(C)CC2)C=C1 LJIOTBMDLVHTBO-CUYJMHBOSA-N 0.000 description 2
- VUDZSIYXZUYWSC-DBRKOABJSA-N (4r)-1-[(2r,4r,5r)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one Chemical compound FC1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N[C@H](O)CC1 VUDZSIYXZUYWSC-DBRKOABJSA-N 0.000 description 2
- VIMMECPCYZXUCI-MIMFYIINSA-N (4s,6r)-6-[(1e)-4,4-bis(4-fluorophenyl)-3-(1-methyltetrazol-5-yl)buta-1,3-dienyl]-4-hydroxyoxan-2-one Chemical compound CN1N=NN=C1C(\C=C\[C@@H]1OC(=O)C[C@@H](O)C1)=C(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 VIMMECPCYZXUCI-MIMFYIINSA-N 0.000 description 2
- IGVKWAAPMVVTFX-BUHFOSPRSA-N (e)-octadec-5-en-7,9-diynoic acid Chemical compound CCCCCCCCC#CC#C\C=C\CCCC(O)=O IGVKWAAPMVVTFX-BUHFOSPRSA-N 0.000 description 2
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 2
- CLUVTXLPRQTDHH-ZDUSSCGKSA-N 1-bromo-4-[(2S)-4-pentoxybutan-2-yl]oxybenzene Chemical compound BrC1=CC=C(C=C1)O[C@H](CCOCCCCC)C CLUVTXLPRQTDHH-ZDUSSCGKSA-N 0.000 description 2
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 description 2
- ILYSAKHOYBPSPC-UHFFFAOYSA-N 2-phenylbenzoic acid Chemical class OC(=O)C1=CC=CC=C1C1=CC=CC=C1 ILYSAKHOYBPSPC-UHFFFAOYSA-N 0.000 description 2
- POKWULIMSISXLX-UHFFFAOYSA-N 3-fluoro-4-phenylmethoxybenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1OCC1=CC=CC=C1 POKWULIMSISXLX-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- YHYICUMUPUBYNN-YTTGMZPUSA-N C(CCCCCCC)C1=CC=C(C=C1)C=1C(=CC=CC1)C1=CC=C(C=C1)O[C@H](COCCCCC)CC Chemical compound C(CCCCCCC)C1=CC=C(C=C1)C=1C(=CC=CC1)C1=CC=C(C=C1)O[C@H](COCCCCC)CC YHYICUMUPUBYNN-YTTGMZPUSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- XEKPAJUTKPMPMM-YTTGMZPUSA-N [(2S)-1-pentoxybutan-2-yl] 4-[2-(4-octoxyphenyl)phenyl]benzoate Chemical compound C(CCCCCCC)OC1=CC=C(C=C1)C=1C(=CC=CC1)C1=CC=C(C=C1)C(=O)O[C@H](COCCCCC)CC XEKPAJUTKPMPMM-YTTGMZPUSA-N 0.000 description 2
- PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 description 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 150000001499 aryl bromides Chemical class 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 238000006473 carboxylation reaction Methods 0.000 description 2
- 229940125773 compound 10 Drugs 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000007333 cyanation reaction Methods 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 2
- 238000000113 differential scanning calorimetry Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 2
- 239000005262 ferroelectric liquid crystals (FLCs) Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000000399 optical microscopy Methods 0.000 description 2
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000003579 shift reagent Substances 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000012258 stirred mixture Substances 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- ILWWHQHPMFKEJF-MRXNPFEDSA-N (2R)-4-dodecoxybutan-2-ol Chemical compound C(CCCCCCCCCCC)OCC[C@@H](C)O ILWWHQHPMFKEJF-MRXNPFEDSA-N 0.000 description 1
- GFASJFDHINSLSI-SECBINFHSA-N (2R)-4-pentoxybutan-2-ol Chemical compound C(CCCC)OCC[C@@H](C)O GFASJFDHINSLSI-SECBINFHSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- DIXMBHMNEHPFCX-MCMMXHMISA-N (2r)-2-[5-[6-amino-5-[(1r)-1-[5-fluoro-2-(triazol-2-yl)phenyl]ethoxy]pyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]propane-1,2-diol Chemical compound O([C@H](C)C=1C(=CC=C(F)C=1)N1N=CC=N1)C(C(=NC=1)N)=CC=1C=1SC([C@](C)(O)CO)=NC=1C DIXMBHMNEHPFCX-MCMMXHMISA-N 0.000 description 1
- PAORVUMOXXAMPL-VIFPVBQESA-N (2r)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoyl chloride Chemical compound CO[C@@](C(Cl)=O)(C(F)(F)F)C1=CC=CC=C1 PAORVUMOXXAMPL-VIFPVBQESA-N 0.000 description 1
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 description 1
- KAFZOLYKKCWUBI-HPMAGDRPSA-N (2s)-2-[[(2s)-2-[[(2s)-1-[(2s)-3-amino-2-[[(2s)-2-[[(2s)-2-(3-cyclohexylpropanoylamino)-4-methylpentanoyl]amino]-5-methylhexanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide Chemical compound N([C@@H](CC(C)C)C(=O)N[C@@H](CCC(C)C)C(=O)N[C@@H](CN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(N)=O)C(=O)CCC1CCCCC1 KAFZOLYKKCWUBI-HPMAGDRPSA-N 0.000 description 1
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 1
- UNGJFDDSOPZFSG-QGZVFWFLSA-N (3R)-1-dodecoxypentan-3-ol Chemical compound C(CCCCCCCCCCC)OCC[C@@H](CC)O UNGJFDDSOPZFSG-QGZVFWFLSA-N 0.000 description 1
- FMDFSJDHZBZBLU-GFCCVEGCSA-N (3R)-3-phenylmethoxypentan-1-ol Chemical compound CC[C@H](CCO)OCc1ccccc1 FMDFSJDHZBZBLU-GFCCVEGCSA-N 0.000 description 1
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 description 1
- SEINCOLPXCLPDL-SNVBAGLBSA-N (3r)-3-phenylmethoxybutan-1-ol Chemical compound OCC[C@@H](C)OCC1=CC=CC=C1 SEINCOLPXCLPDL-SNVBAGLBSA-N 0.000 description 1
- FOLCUFKJHSQMEL-BIXPGCQOSA-N (4-butylcyclohexyl) N-[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]pentan-2-yl]carbamate Chemical compound CCCCC1CCC(CC1)OC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]2CCNC2=O)C=O FOLCUFKJHSQMEL-BIXPGCQOSA-N 0.000 description 1
- PNHBRYIAJCYNDA-VQCQRNETSA-N (4r)-6-[2-[2-ethyl-4-(4-fluorophenyl)-6-phenylpyridin-3-yl]ethyl]-4-hydroxyoxan-2-one Chemical compound C([C@H](O)C1)C(=O)OC1CCC=1C(CC)=NC(C=2C=CC=CC=2)=CC=1C1=CC=C(F)C=C1 PNHBRYIAJCYNDA-VQCQRNETSA-N 0.000 description 1
- FRJJJAKBRKABFA-TYFAACHXSA-N (4r,6s)-6-[(e)-2-[6-chloro-4-(4-fluorophenyl)-2-propan-2-ylquinolin-3-yl]ethenyl]-4-hydroxyoxan-2-one Chemical compound C(\[C@H]1OC(=O)C[C@H](O)C1)=C/C=1C(C(C)C)=NC2=CC=C(Cl)C=C2C=1C1=CC=C(F)C=C1 FRJJJAKBRKABFA-TYFAACHXSA-N 0.000 description 1
- QOLHWXNSCZGWHK-BWBORTOCSA-N (6r,7r)-1-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-4,7-dihydroxy-6-(11-phenoxyundecylcarbamoyloxy)-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid Chemical compound C([C@@H](C)[C@H](OC(C)=O)C(=C)CCC12[C@@H]([C@@H](OC(=O)NCCCCCCCCCCCOC=3C=CC=CC=3)C(O1)(C(O)=O)C(O)(C(O2)C(O)=O)C(O)=O)O)C1=CC=CC=C1 QOLHWXNSCZGWHK-BWBORTOCSA-N 0.000 description 1
- UXKLQDCALAWFIU-VKNDCNMPSA-N (6r,7r)-1-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-4,7-dihydroxy-6-tetradecoxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid Chemical compound C([C@@H](C)[C@H](OC(C)=O)C(=C)CCC12[C@H](O)[C@H](C(O2)(C(O)=O)C(O)(C(O1)C(O)=O)C(O)=O)OCCCCCCCCCCCCCC)C1=CC=CC=C1 UXKLQDCALAWFIU-VKNDCNMPSA-N 0.000 description 1
- VGNCBRNRHXEODV-XXVHXNRLSA-N (6r,7r)-1-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-6-dodecoxy-4,7-dihydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid Chemical compound C([C@@H](C)[C@H](OC(C)=O)C(=C)CCC12[C@H](O)[C@H](C(O2)(C(O)=O)C(O)(C(O1)C(O)=O)C(O)=O)OCCCCCCCCCCCC)C1=CC=CC=C1 VGNCBRNRHXEODV-XXVHXNRLSA-N 0.000 description 1
- YKYIFUROKBDHCY-ONEGZZNKSA-N (e)-4-ethoxy-1,1,1-trifluorobut-3-en-2-one Chemical group CCO\C=C\C(=O)C(F)(F)F YKYIFUROKBDHCY-ONEGZZNKSA-N 0.000 description 1
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- JZJSOSKVBYYDHQ-UHFFFAOYSA-N 1-bromo-4-(4-octoxyphenyl)benzene Chemical group C1=CC(OCCCCCCCC)=CC=C1C1=CC=C(Br)C=C1 JZJSOSKVBYYDHQ-UHFFFAOYSA-N 0.000 description 1
- UPQQXPKAYZYUKO-UHFFFAOYSA-N 2,2,2-trichloroacetamide Chemical compound OC(=N)C(Cl)(Cl)Cl UPQQXPKAYZYUKO-UHFFFAOYSA-N 0.000 description 1
- JGMXNNSYEFOBHQ-OWOJBTEDSA-N 2-[(e)-4-morpholin-4-ylbut-2-enyl]-1,1-dioxothieno[3,2-e]thiazine-6-sulfonamide Chemical compound O=S1(=O)C=2SC(S(=O)(=O)N)=CC=2C=CN1C\C=C\CN1CCOCC1 JGMXNNSYEFOBHQ-OWOJBTEDSA-N 0.000 description 1
- AKBHYCHPWZPGAH-UHFFFAOYSA-N 2-[3-[(3-chloro-4-methylphenyl)methoxy]azetidine-1-carbonyl]-7-oxa-5-azaspiro[3.4]octan-6-one Chemical compound CC1=C(Cl)C=C(COC2CN(C2)C(=O)C2CC3(C2)COC(=O)N3)C=C1 AKBHYCHPWZPGAH-UHFFFAOYSA-N 0.000 description 1
- LHASZEBEQGPCFM-CJFMBICVSA-N 2-amino-4-[(1r)-1-[[(6r)-6-[(5-chloro-2-methoxyphenyl)methyl]-7-oxo-3-(phenoxyamino)-5,6-dihydro-2h-1,4-diazepine-1-carbonyl]amino]propyl]benzoic acid Chemical compound C([C@@H]1CNC(CN(C1=O)C(=O)N[C@H](CC)C=1C=C(N)C(C(O)=O)=CC=1)=NOC=1C=CC=CC=1)C1=CC(Cl)=CC=C1OC LHASZEBEQGPCFM-CJFMBICVSA-N 0.000 description 1
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 1
- MWDVCHRYCKXEBY-LBPRGKRZSA-N 3-chloro-n-[2-oxo-2-[[(1s)-1-phenylethyl]amino]ethyl]benzamide Chemical compound N([C@@H](C)C=1C=CC=CC=1)C(=O)CNC(=O)C1=CC=CC(Cl)=C1 MWDVCHRYCKXEBY-LBPRGKRZSA-N 0.000 description 1
- MXNBDFWNYRNIBH-UHFFFAOYSA-N 3-fluorobenzoic acid Chemical compound OC(=O)C1=CC=CC(F)=C1 MXNBDFWNYRNIBH-UHFFFAOYSA-N 0.000 description 1
- HPZPFOIOJPBNKK-UHFFFAOYSA-N 4-(4-dodecoxyphenyl)benzoic acid Chemical compound C1=CC(OCCCCCCCCCCCC)=CC=C1C1=CC=C(C(O)=O)C=C1 HPZPFOIOJPBNKK-UHFFFAOYSA-N 0.000 description 1
- XDCOYBQVEVSNNB-UHFFFAOYSA-N 4-[(7-naphthalen-2-yl-1-benzothiophen-2-yl)methylamino]butanoic acid Chemical compound OC(=O)CCCNCc1cc2cccc(-c3ccc4ccccc4c3)c2s1 XDCOYBQVEVSNNB-UHFFFAOYSA-N 0.000 description 1
- HCVUDNMNSPYSHS-UHFFFAOYSA-N 4-bromo-2-fluoro-1-phenylmethoxybenzene Chemical compound FC1=CC(Br)=CC=C1OCC1=CC=CC=C1 HCVUDNMNSPYSHS-UHFFFAOYSA-N 0.000 description 1
- GZFGOTFRPZRKDS-UHFFFAOYSA-N 4-bromophenol Chemical compound OC1=CC=C(Br)C=C1 GZFGOTFRPZRKDS-UHFFFAOYSA-N 0.000 description 1
- FOQJFNDGCQAUCE-UHFFFAOYSA-N 4-methoxycarbonyloxybenzoic acid Chemical compound COC(=O)OC1=CC=C(C(O)=O)C=C1 FOQJFNDGCQAUCE-UHFFFAOYSA-N 0.000 description 1
- LDIOUQIXNSSOGU-UHFFFAOYSA-N 8-(3-pentylamino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5h-cyclopenta[d]pyrazolo[1,5-a]pyrimidine Chemical compound CC1=NN2C(NC(CC)CC)=C3CCCC3=NC2=C1C1=CC=C(OC)C=C1Cl LDIOUQIXNSSOGU-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- MZOHKWPCEYTTND-XMMPIXPASA-N C(C1=CC=CC=C1)O[C@@H](CCOCCCCCCCCCCCC)CC Chemical compound C(C1=CC=CC=C1)O[C@@H](CCOCCCCCCCCCCCC)CC MZOHKWPCEYTTND-XMMPIXPASA-N 0.000 description 1
- AAQBUSQPFYDRKJ-SECBINFHSA-N C(CCCC)OC[C@@H](CC)O Chemical compound C(CCCC)OC[C@@H](CC)O AAQBUSQPFYDRKJ-SECBINFHSA-N 0.000 description 1
- BLQHXMYFDMQTAS-UHFFFAOYSA-N C(CCCCCCCCCCC)OC1=CC=C(C=C1)C1=CC=C(C=C1)C(=O)OF Chemical group C(CCCCCCCCCCC)OC1=CC=C(C=C1)C1=CC=C(C=C1)C(=O)OF BLQHXMYFDMQTAS-UHFFFAOYSA-N 0.000 description 1
- XUEOLBVJXCOWKF-MRVPVSSYSA-N CCCCOCC[C@@H](C)O Chemical compound CCCCOCC[C@@H](C)O XUEOLBVJXCOWKF-MRVPVSSYSA-N 0.000 description 1
- KWPXMPYWPWRZCR-GFCCVEGCSA-N CCC[C@H](C(=O)O)OCC1=CC=CC(=C1)C Chemical compound CCC[C@H](C(=O)O)OCC1=CC=CC(=C1)C KWPXMPYWPWRZCR-GFCCVEGCSA-N 0.000 description 1
- PIYVGPKPVKCJMQ-ZCFIWIBFSA-N CCOCC[C@@H](C)O Chemical compound CCOCC[C@@H](C)O PIYVGPKPVKCJMQ-ZCFIWIBFSA-N 0.000 description 1
- METPUBMTPUYMGR-RXMQYKEDSA-N COCC[C@@H](C)O Chemical compound COCC[C@@H](C)O METPUBMTPUYMGR-RXMQYKEDSA-N 0.000 description 1
- 229940126639 Compound 33 Drugs 0.000 description 1
- 229940126559 Compound 4e Drugs 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- 238000000023 Kugelrohr distillation Methods 0.000 description 1
- LDLDJEAVRNAEBW-UHFFFAOYSA-N Methyl 3-hydroxybutyrate Chemical compound COC(=O)CC(C)O LDLDJEAVRNAEBW-UHFFFAOYSA-N 0.000 description 1
- TZYWCYJVHRLUCT-VABKMULXSA-N N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal Chemical compound CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1 TZYWCYJVHRLUCT-VABKMULXSA-N 0.000 description 1
- TZCCKCLHNUSAMQ-DUGSHLAESA-N NC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)Cc5cccs5)C(=O)N Chemical compound NC(=O)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)Cc5cccs5)C(=O)N TZCCKCLHNUSAMQ-DUGSHLAESA-N 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- 229940125907 SJ995973 Drugs 0.000 description 1
- PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000006069 Suzuki reaction reaction Methods 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 1
- YOFUMOXLLPQQFJ-CQSZACIVSA-N [(2R)-4-butoxybutan-2-yl]oxymethylbenzene Chemical compound C(C1=CC=CC=C1)O[C@@H](CCOCCCC)C YOFUMOXLLPQQFJ-CQSZACIVSA-N 0.000 description 1
- QMCXJYPRBXRDAJ-JOCHJYFZSA-N [(2R)-4-dodecoxybutan-2-yl]oxymethylbenzene Chemical compound C(C1=CC=CC=C1)O[C@@H](CCOCCCCCCCCCCCC)C QMCXJYPRBXRDAJ-JOCHJYFZSA-N 0.000 description 1
- DYLJODFRDQKYCB-GFCCVEGCSA-N [(2R)-4-ethoxybutan-2-yl]oxymethylbenzene Chemical compound C(C1=CC=CC=C1)O[C@@H](CCOCC)C DYLJODFRDQKYCB-GFCCVEGCSA-N 0.000 description 1
- KAOBKWJNPAIOIU-LLVKDONJSA-N [(2R)-4-methoxybutan-2-yl]oxymethylbenzene Chemical compound C(C1=CC=CC=C1)O[C@@H](CCOC)C KAOBKWJNPAIOIU-LLVKDONJSA-N 0.000 description 1
- BLYWFUQLKOYOPF-OAHLLOKOSA-N [(2R)-4-pentoxybutan-2-yl]oxymethylbenzene Chemical compound C(C1=CC=CC=C1)O[C@@H](CCOCCCCC)C BLYWFUQLKOYOPF-OAHLLOKOSA-N 0.000 description 1
- QBZCOYNCELNLTH-XMMPIXPASA-N [(2R)-4-tetradecoxybutan-2-yl]oxymethylbenzene Chemical compound C(C1=CC=CC=C1)O[C@@H](CCOCCCCCCCCCCCCCC)C QBZCOYNCELNLTH-XMMPIXPASA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- HUZCTWYDQIQZPM-UHFFFAOYSA-N benzyl 2,2,2-trichloroethanimidate Chemical compound ClC(Cl)(Cl)C(=N)OCC1=CC=CC=C1 HUZCTWYDQIQZPM-UHFFFAOYSA-N 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 229940126142 compound 16 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 229940127204 compound 29 Drugs 0.000 description 1
- 229940125878 compound 36 Drugs 0.000 description 1
- 229940125807 compound 37 Drugs 0.000 description 1
- 229940125936 compound 42 Drugs 0.000 description 1
- 229940125872 compound 4d Drugs 0.000 description 1
- 229940126115 compound 4f Drugs 0.000 description 1
- 229940125801 compound 7f Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- NPOMSUOUAZCMBL-UHFFFAOYSA-N dichloromethane;ethoxyethane Chemical compound ClCCl.CCOCC NPOMSUOUAZCMBL-UHFFFAOYSA-N 0.000 description 1
- WBKFWQBXFREOFH-UHFFFAOYSA-N dichloromethane;ethyl acetate Chemical compound ClCCl.CCOC(C)=O WBKFWQBXFREOFH-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229940052303 ethers for general anesthesia Drugs 0.000 description 1
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000003709 fluoroalkyl group Chemical group 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- XHFXKKFVUDJSPJ-RXMQYKEDSA-N methyl (3r)-3-hydroxypentanoate Chemical compound CC[C@@H](O)CC(=O)OC XHFXKKFVUDJSPJ-RXMQYKEDSA-N 0.000 description 1
- JXBBMSDQNOELFF-SNVBAGLBSA-N methyl (3r)-3-phenylmethoxybutanoate Chemical compound COC(=O)C[C@@H](C)OCC1=CC=CC=C1 JXBBMSDQNOELFF-SNVBAGLBSA-N 0.000 description 1
- BGXZIBSLBRKDTP-UHFFFAOYSA-N methyl 9-(4-chloroanilino)-[1,3]thiazolo[5,4-f]quinazoline-2-carboximidate Chemical compound C12=C3SC(C(=N)OC)=NC3=CC=C2N=CN=C1NC1=CC=C(Cl)C=C1 BGXZIBSLBRKDTP-UHFFFAOYSA-N 0.000 description 1
- PQIOSYKVBBWRRI-UHFFFAOYSA-N methylphosphonyl difluoride Chemical group CP(F)(F)=O PQIOSYKVBBWRRI-UHFFFAOYSA-N 0.000 description 1
- OKDQKPLMQBXTNH-UHFFFAOYSA-N n,n-dimethyl-2h-pyridin-1-amine Chemical compound CN(C)N1CC=CC=C1 OKDQKPLMQBXTNH-UHFFFAOYSA-N 0.000 description 1
- PHHRKRGXWSEXFZ-UHFFFAOYSA-N n-(pyridin-3-ylmethyl)-3-[[2-[(2,3,4-trifluorophenoxy)methyl]-1,3-benzoxazol-4-yl]oxy]propan-1-amine Chemical compound FC1=C(F)C(F)=CC=C1OCC(OC1=CC=C2)=NC1=C2OCCCNCC1=CC=CN=C1 PHHRKRGXWSEXFZ-UHFFFAOYSA-N 0.000 description 1
- RCSBCWXPGSPJNF-UHFFFAOYSA-N n-[4-[5-[3-chloro-4-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]butyl]-4-(1,8-naphthyridin-2-yl)butanamide Chemical compound C1=C(Cl)C(OC(F)(F)F)=CC=C1C(O1)=NN=C1CCCCNC(=O)CCCC1=CC=C(C=CC=N2)C2=N1 RCSBCWXPGSPJNF-UHFFFAOYSA-N 0.000 description 1
- XZMHJYWMCRQSSI-UHFFFAOYSA-N n-[5-[2-(3-acetylanilino)-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]benzamide Chemical compound CC(=O)C1=CC=CC(NC=2SC=C(N=2)C2=C(N=C(NC(=O)C=3C=CC=CC=3)S2)C)=C1 XZMHJYWMCRQSSI-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 229910021420 polycrystalline silicon Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005591 polysilicon Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- RWWYLEGWBNMMLJ-YSOARWBDSA-N remdesivir Chemical compound NC1=NC=NN2C1=CC=C2[C@]1([C@@H]([C@@H]([C@H](O1)CO[P@](=O)(OC1=CC=CC=C1)N[C@H](C(=O)OCC(CC)CC)C)O)O)C#N RWWYLEGWBNMMLJ-YSOARWBDSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- WRECIMRULFAWHA-UHFFFAOYSA-N trimethyl borate Chemical compound COB(OC)OC WRECIMRULFAWHA-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/02—Liquid crystal materials characterised by optical, electrical or physical properties of the components, in general
- C09K19/0266—Antiferroelectrics
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/137—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells characterised by the electro-optical or magneto-optical effect, e.g. field-induced phase transition, orientation effect, guest-host interaction or dynamic scattering
- G02F1/139—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells characterised by the electro-optical or magneto-optical effect, e.g. field-induced phase transition, orientation effect, guest-host interaction or dynamic scattering based on orientation effects in which the liquid crystal remains transparent
- G02F1/141—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells characterised by the electro-optical or magneto-optical effect, e.g. field-induced phase transition, orientation effect, guest-host interaction or dynamic scattering based on orientation effects in which the liquid crystal remains transparent using ferroelectric liquid crystals
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/137—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells characterised by the electro-optical or magneto-optical effect, e.g. field-induced phase transition, orientation effect, guest-host interaction or dynamic scattering
- G02F1/139—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells characterised by the electro-optical or magneto-optical effect, e.g. field-induced phase transition, orientation effect, guest-host interaction or dynamic scattering based on orientation effects in which the liquid crystal remains transparent
- G02F1/141—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells characterised by the electro-optical or magneto-optical effect, e.g. field-induced phase transition, orientation effect, guest-host interaction or dynamic scattering based on orientation effects in which the liquid crystal remains transparent using ferroelectric liquid crystals
- G02F1/1412—Antiferroelectric liquid crystals
Landscapes
- Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Nonlinear Science (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Liquid Crystal (AREA)
- Liquid Crystal Substances (AREA)
Abstract
본 발명은 액정층이 1종 이상의 하기 화학식 106의 화합물을 포함하는 반강유전성 액정 소자를 개시하고 있다. 본 발명은 또한 X가 F인 신규한 화학식 106의 화합물 및 이 화합물의 제조 방법을 개시하고 있다.The present invention discloses a semiferroelectric liquid crystal device in which the liquid crystal layer comprises at least one compound represented by the following Chemical Formula 106. The present invention also discloses a novel compound of formula 106 wherein X is F and a process for preparing the compound.
상기 식에서, a는 1 내지 16이고, b는 1 또는 2이며, c는 1 내지 14이고, n, p 및 r은 각각 독립적으로 0 또는 1이며, 고리 A 및 B는 각각 독립적으로 시클로헥실, 비치환된 페닐, 모노-플루오로페닐, 디플루오로페닐, 디옥사닐, 피리미딜 및 피리디닐로 구성되는 군으로부터 선택되고, X는 H 또는 F이며, Y 및 Z는 각각 독립적으로 C-C, C≡C, CO2, O2C 및 O로 구성되는 군으로부터 선택되고, (*)는 비대칭 탄소 원자를 나타낸다.Wherein a is 1 to 16, b is 1 or 2, c is 1 to 14, n, p and r are each independently 0 or 1, and rings A and B are each independently cyclohexyl, non Ring phenyl, mono-fluorophenyl, difluorophenyl, dioxanyl, pyrimidyl and pyridinyl, X is H or F, and Y and Z are each independently CC, C≡ C, CO 2 , O 2 C and O, and (*) represents an asymmetric carbon atom.
Description
본 발명은 반강유전성 디스플레이 소자 및 이 소자에 사용하기 위한 반강유전성 화합물 및 조성물에 관한 것이다.The present invention relates to antiferroelectric display devices and antiferroelectric compounds and compositions for use in the devices.
적절한 조건하에 액정 상을 나타내는 많은 화합물이 합성되어 있다. 실제 액정 디스플레이 소자의 경우, 이러한 화합물 (일반적으로 다른 화합물과의 혼합물로)은 디스플레이에 광범위한 시야각, 큰 콘트라스트비, 고속 반응 및 저전압 작동을 부여하는데 필요하다.Many compounds which show a liquid crystal phase under appropriate conditions are synthesized. In the case of real liquid crystal display devices, these compounds (usually in mixtures with other compounds) are necessary to give the display a wide viewing angle, large contrast ratio, fast response and low voltage operation.
문헌 (S. Inui 등, J. Mater. Chem. 1996 6(4) pp. 671-673)에는 일련의 하기 화학식 101의 화합물이 개시되어 있다. 이러한 화합물의 3성분 혼합물은 35˚초과의 틸트각, 100 이하의 콘트라스트비, 60˚초과의 광범위한 시야각 및 임계가 없는 AF-F 전이를 나타낸다.S. Inui et al., J. Mater. Chem. 1996 6 (4) pp. 671-673 disclose a series of compounds of formula (101). Three-component mixtures of these compounds exhibit tilt angles above 35 °, contrast ratios below 100, wide viewing angles above 60 °, and no critical AF-F transitions.
문헌 (C.J. Booth 등, Liquid Crystals 1996 20(6) pp. 815-823)에는 하기 화학식 102의 화합물이 개시되어 있고, A = CH2F이고 B = CH2OC6H13인 화합물은 반강유전성 상을 나타내지 않았다.(CJ Booth et al., Liquid Crystals 1996 20 (6) pp. 815-823) disclose compounds of formula 102, wherein A = CH 2 F and B = CH 2 OC 6 H 13 are antiferroelectric phases. Not shown.
상기 식에서, A = 알킬 또는 플루오로알킬, B = 알킬 또는 CH2O-알킬이다.Wherein A = alkyl or fluoroalkyl, B = alkyl or CH 2 O-alkyl.
일본 특허 제7-252479호, 제8-218070호, 제9-157224호 및 제7-316100호에는 분자의 각 대향 말단에 지방족 말단 사슬, 및 키랄 탄소에 결합된 플루오로메틸기 및 알콕시알킬기를 갖는 키랄 말단 사슬을 갖는 비페닐-카르보닐옥시-페닐 코어를 갖는 유사한 화합물이 개시되어 있다. 이들 화합물은 반강유전성 거동 (키랄 스멕틱 CA(SA) 상의 존재를 특징으로 함)을 나타내고, 신속한 스위칭 시간을 갖는다. 키랄 측쇄가 CH(CF3)(CH2)5OC2H5인 일본 특허 제7-316100호의 실시예 1은 43 내지 93 ℃의 SA상 범위 및 32˚의 틸트각을 갖는다. 일본 특허 제8-218069호에는 또한 유사한 화합물 및 비페닐기가 1,3-디옥산-2-일 페닐기로 대체된 화합물이 개시되어 있다.Japanese Patent Nos. 7-252479, 8-218070, 9-157224 and 7-316100 have aliphatic end chains at each opposite end of the molecule, and a fluoromethyl group and an alkoxyalkyl group bonded to chiral carbon. Similar compounds with biphenyl-carbonyloxy-phenyl cores having chiral end chains are disclosed. These compounds exhibit antiferroelectric behavior (characterized by the presence of chiral smectic C A (S A ) phases) and have a fast switching time. Example 1 of Japanese Patent No. 7-316100 having a chiral side chain of CH (CF 3 ) (CH 2 ) 5 OC 2 H 5 has a S A phase range of 43 to 93 ° C. and a tilt angle of 32 °. Japanese Patent No. 8-218069 also discloses a similar compound and a compound in which a biphenyl group is replaced with a 1,3-dioxan-2-yl phenyl group.
유럽 특허 제0617109호에는 키랄 말단 사슬을 갖는 일련의 테트랄린 기재 액정 물질이 개시되어 있다. 키랄 측쇄가 에테르를 함유하는 특정 실시예 (하기 화학식 103)는 좁은 반강유전성 상을 나타낸다.EP 0617109 discloses a series of tetralin based liquid crystal materials having chiral end chains. Certain examples in which the chiral side chain contains ethers (Formula 103) show a narrow antiferroelectric phase.
국제 특허 공개 제96/30330호 및 일본 특허 제6-228056호에도 키랄(*) 탄소에 결합된 트리플루오로메틸기 및 알콕시알킬기를 갖는 유사한 테트랄린 기재 액정 물질이 개시되어 있다.International Patent Publication Nos. 96/30330 and 6-228056 also disclose similar tetralin based liquid crystal materials having trifluoromethyl and alkoxyalkyl groups bonded to chiral (*) carbons.
문헌 (S.L. Wu, Liquid Crystals 1995 18(5) pp. 715-721)에는 일련의 하기 화학식 104의 화합물이 개시되어 잇다. 모든 화합물은 SA상 (가장 넓은 SA상 범위는 m = 12의 경우 83 내지 140 ℃임)을 나타낸다.SL Wu, Liquid Crystals 1995 18 (5) pp. 715-721 discloses a series of compounds of formula All compounds exhibit an S A phase (the widest S A phase range is 83 to 140 ° C. for m = 12).
유럽 특허 제A-0360622호 및 미국 특허 제A-5693251호에는 강유전성 액정 디스플레이에 유용할 수 있는 매우 광범위한 액정 화합물이 개시되어 있다. 이들 화합물 중에는 화학식EP-A-0360622 and US-A-5693251 disclose a wide variety of liquid crystal compounds that may be useful in ferroelectric liquid crystal displays. Among these compounds,
의 화합물이 개시되어 있다.Compounds of are disclosed.
그러나, 이들 화합물이 반강유전성 상을 나타낼 수 있는 것으로는 제안되어 있지 않다.However, it is not suggested that these compounds can exhibit antiferroelectric phases.
유럽 특허 제A-0357435호에도 또한 강유전성 액정 디스플레이에 유용할 수 있는 매우 광범위한 액정 화합물이 개시되어 있다. 이들 화합물 중에는 화학식EP-A-0357435 also discloses a wide range of liquid crystal compounds that can be useful in ferroelectric liquid crystal displays. Among these compounds,
의 화합물이 개시되어 있다.Compounds of are disclosed.
그러나, 반강유전성 상의 존재는 제안되어 있지 않다.However, the presence of antiferroelectric phases is not proposed.
일본 특허 공개 제63310848호에는 강유전성 액정으로 유용한 하기 화학식 105의 화합물이 개시되어 있다.Japanese Patent Laid-Open No. 63210848 discloses a compound of formula 105 useful as a ferroelectric liquid crystal.
상기 식에서, R1은 C6-12알킬이고, R2는 C3-5광학 활성기이며, R3은 C1-6알킬이고 n은 0 또는 1이다.Wherein R 1 is C 6-12 alkyl, R 2 is C 3-5 optically active group, R 3 is C 1-6 alkyl and n is 0 or 1.
특히, 이 문헌에는 화학식In particular, this document includes
의 화합물이 개시되어 있다.Compounds of are disclosed.
그러나, 이러한 화합물 중에서 반강유전성 상의 존재는 개시되어 있지 않다.However, the presence of antiferroelectric phases in these compounds is not disclosed.
본 발명의 목적은 신규한 반강유전성 액정 소자를 제공하는 것이다.It is an object of the present invention to provide a novel antiferroelectric liquid crystal device.
도 1 내지 5는 본 발명에 사용되는 각종 화합물에 대한 원뿔각을 온도에 대해 플롯한 그래프.1 to 5 are graphs plotting the cone angle versus temperature for various compounds used in the present invention.
도 6은 본 발명에 다른 액정 소자의 일례에서 능동 매트릭스 어레이의 전형적인 셀 (화소) 부분의 개략도.6 is a schematic diagram of a typical cell (pixel) portion of an active matrix array in one example of a liquid crystal element in accordance with the present invention.
도 7a 및 7b는 도 6의 소자에서 어레이에 대한 어드레싱 도식에서 사용되는 교대 스위칭 파형을 보여주는 도면.7A and 7B show alternate switching waveforms used in the addressing scheme for an array in the device of FIG. 6.
도 8 및 9는 어레이를 어드레싱하기 위한 교대 능동 회로의 도면.8 and 9 illustrate alternate active circuits for addressing an array.
<도면의 주요 부분에 대한 부호의 설명><Explanation of symbols for the main parts of the drawings>
(2), (4): 투과성 기판 (6): 기판 사이의 간격(2), (4): transparent substrate (6): gap between substrates
(8): 투과성 전극 (9): 배열층(8): transparent electrode (9): array layer
(10): 매트릭스 어레이 (12): 데이타 드라이버(10): matrix array (12): data driver
(14): 주사 드라이버 (18): 트랜지스터14: scan driver 18 transistors
(20): 전극 (22): 데이타 전극(20): electrode (22): data electrode
(24): 축전기 (28): 완충 증폭기(24): capacitor (28): buffer amplifier
본 발명의 제1면은 한쌍의 기판, 기판 사이에 배치된 반강유전성 액정 물질의 층, 및 상기 층 중의 반강유전성 상의 형성을 조절하기 위해 층을 가로질러 전압을 인가하기 위한 전압 인가 수단을 포함하는 액정 소자를 제공하는 것으로서, 반강유전성 물질이 하기 화학식 106의 화합물을 포함하는 것을 특징으로 한다.The first aspect of the invention includes a pair of substrates, a layer of antiferroelectric liquid crystal material disposed between the substrates, and voltage application means for applying a voltage across the layer to control the formation of the antiferroelectric phase in the layer. As providing a liquid crystal device, the anti-ferroelectric material is characterized in that it comprises a compound of the formula (106).
<화학식 106><Formula 106>
상기 식에서, a는 1 내지 16이고, b는 1 또는 2이며, c는 1 내지 14이고, n, p 및 r은 각각 독립적으로 0 또는 1이며, 고리 A 및 B는 각각 독립적으로 시클로헥실, 비치환된 페닐, 모노-플루오로페닐, 디플루오로페닐, 디옥사닐, 피리미딜 및 피리디닐로 구성되는 군으로부터 선택되고, X는 H 또는 F이며, Y 및 Z는 각각 독립적으로 C-C, C≡C, CO2, O2C 및 O로 구성되는 군으로부터 선택되고, (*)는 비대칭 탄소 원자를 나타낸다.Wherein a is 1 to 16, b is 1 or 2, c is 1 to 14, n, p and r are each independently 0 or 1, and rings A and B are each independently cyclohexyl, non Ring phenyl, mono-fluorophenyl, difluorophenyl, dioxanyl, pyrimidyl and pyridinyl, X is H or F, and Y and Z are each independently CC, C≡ C, CO 2 , O 2 C and O, and (*) represents an asymmetric carbon atom.
비대칭 탄소 중심 (*)으로 인해, 화학식 106으로 나타내어지는 각 구조의 경우 한쌍의 에난티오머가 존재한다.Due to the asymmetric carbon center (*), there is a pair of enantiomers for each structure represented by formula (106).
바람직하게는, c는 1 내지 11 (보다 바람직하게는 1 내지 5)이고(이거나) n은 1이고(이거나) 고리 A는 비치환된 페닐이고(이거나) 고리 B는 비치환된 페닐이고(이거나) X는 H이고(이거나) Y는 CO2이고(이거나) Z는 CO2이다.Preferably, c is 1 to 11 (more preferably 1 to 5) and / or n is 1 and ring A is unsubstituted phenyl and ring B is unsubstituted phenyl X is H and Y is CO 2 and Z is CO 2 .
보다 바람직하게는, c는 1 내지 5이고, 고리 A 및 B는 각각 비치환된 페닐이며, X는 H이고, Y 및 Z 각각은 CO2이며, n은 1이다.More preferably, c is 1 to 5, rings A and B are each unsubstituted phenyl, X is H, Y and Z are each CO 2 and n is 1.
바람직하게는, 화학식 106의 화합물은 반강유전성 거동을 나타낸다. 이러한 반강유전성 거동은 키랄 스멕틱 CA(SA) 상의 존재를 특징으로 한다.Preferably, the compound of formula 106 exhibits antiferroelectric behavior. This antiferroelectric behavior is characterized by the presence of chiral smectic C A (S A ) phases.
보다 바람직하게는, 화합물의 SA상 온도 범위는 70 ℃를 초과하고(하거나), 화합물은 45 ℃ 미만에서 반강유전성 SA상으로 존재할 수 있다.More preferably, the S A phase temperature range of the compound is above 70 ° C. and / or the compound may be present as an antiferroelectric S A phase below 45 ° C.
화합물은 임계가 없는 반강유전성 거동을 나타낼 수 있다. 이러한 임계가없는 반강유전성 거동은 반강유전성 SA상 및 강유전성 상, 예를 들어 S 상 사이의 자발인 전이를 특징으로 한다 (예를 들어, A. Fukuda, Proceedings of 15th International Display Research Conference, Asia Display 1995 pp. 61-64 및 S. Inui 등의 상기 문헌 참조).Compounds can exhibit critical nonferroelectric behavior. This thresholdless antiferroelectric behavior is characterized by a spontaneous transition between antiferroelectric S A phase and ferroelectric phase, for example S phase (eg, A. Fukuda, Proceedings of 15th International Display Research Conference, Asia Display). 1995 pp. 61-64 and S. Inui et al., Supra).
바람직하게는, 화합물은 어두운 상태에서 투과 상태로의 신속한 스위칭 (τ온: 0.65 ms 미만, 보다 바람직하게는 0.4 ms 미만) 및(또는) 투과 상태에서 어두운 상태로의 신속한 스위칭 (τ오프: 5.1 ms 미만, 보다 바람직하게는 2.6 ms 미만)을 나타낸다.Preferably, the compound is capable of rapid switching from the dark state to the transmissive state (τ temperature: less than 0.65 ms, more preferably less than 0.4 ms) and / or rapid switching from the transmissive state to the dark state (τ off: 5.1 ms). Less than, more preferably less than 2.6 ms).
바람직하게는, 투과 상태에서의 변화에 대한 임계 전압은 5 V 이하, 보다 바람직하게는 4 V 미만이다.Preferably, the threshold voltage for changes in the transmission state is 5 V or less, more preferably less than 4 V.
바람직하게는, 화합물은 임계 전압 근처에서 전압을 변화시킴에 따라 비선형 투과 거동을 나타내어 전압의 변화는 투과에서 비교적 작은 변화를 일으킨다. 이것은, 액정 화소에 인가되는 전압에서 에러가 있는 경우, 선형 투과 액정 물질을 혼입한 특정 능동 매트릭스 액정 디스플레이에서 어두운 상태의 빛의 누출의 혼란으로 인한 콘트라스트가 감소되는 문제점을 극복하는데 유리하다.Preferably, the compound exhibits nonlinear transmission behavior as the voltage changes near the threshold voltage such that the change in voltage results in a relatively small change in transmission. This is advantageous in overcoming the problem that, in the case of an error in the voltage applied to the liquid crystal pixels, the contrast is reduced due to the confusion of light leakage in the dark state in certain active matrix liquid crystal displays incorporating linear transmissive liquid crystal materials.
바람직하게는, 화합물은 65 nC/㎠ 미만, 보다 바람직하게는 55 nC/㎠ 미만, 가장 바람직하게는 35 nC/㎠ 미만의 자발 분극 계수 (PS)를 갖는다.Preferably, the compound has a spontaneous polarization coefficient (P S ) of less than 65 nC / cm 2, more preferably less than 55 nC / cm 2, most preferably less than 35 nC / cm 2.
본 발명자들은 a가 12이고 b는 1이며 c가 1 내지 5이고 n, p 및 r은 각각 1이며 고리 A 및 B는 각각 비치환된 페닐이고 X는 H이며 Y 및 Z는 각각 CO2인 화학식106의 화합물은 전술한 광범위한 반강유전성 SA상, 낮은 스위칭 시간, 전압 및 분극 계수를 나타내는 화합물의 예임을 발견하였다.The inventors have formulas wherein a is 12, b is 1, c is 1 to 5, n, p and r are each 1, rings A and B are unsubstituted phenyl and X is H and Y and Z are each CO 2 Compound 106 was found to be an example of a compound exhibiting the broad range of antiferroelectric S A phases described above, low switching time, voltage and polarization coefficient.
본 발명의 제2면은 (i) 키랄 스멕틱 CA(SA) 상을 나타내고(거나), X, 고리 A 및 고리 B 중 하나 이상에서 불소기를 갖는, 전술한 바와 같은 화학식 106의 화합물을 제공한다.The second aspect of the present invention provides a compound of formula 106 as described above wherein (i) a chiral smectic C A (S A ) phase and / or having a fluorine group in at least one of X, ring A and ring B to provide.
고리 A 및(또는) 고리 B는 하나 이상의 불소 원자에 의해 치환된 페닐기일 수 있다.Ring A and / or Ring B may be a phenyl group substituted by one or more fluorine atoms.
본 발명의 제3면은 하기 화학식 107의 화합물의 제조를 위한 입체선택적인 방법을 제공하는 것으로서, 이 방법은The third aspect of the present invention provides a stereoselective method for the preparation of a compound of formula
(i) 하기 화학식 107a의 화합물을 하기 화학식 107b의 화합물로 전환시키고,(i) converting the compound of formula 107a to the compound of formula 107b,
(ii) 화학식 107b의 화합물 및 하기 화학식 107c의 화합물 사이에 에스테르 결합을 형성하여 하기 화학식 107d의 화합물을 얻고,(ii) forming an ester bond between the compound of Formula 107b and the compound of Formula 107c to obtain a compound of Formula 107d,
(iii) 화학식 107d의 화합물의 B를 H로 전환시키고,(iii) converting B of the compound of formula 107d to H,
(iv) 단계 (iii)의 비차단된 화합물 및 하기 화학식 107e의 화합물 사이에 에스테르 결합을 형성하여 화학식 107의 화합물을 제조하는 순차적인 단계를 포함한다.(iv) forming a ester bond between the unblocked compound of step (iii) and the compound of formula 107e to prepare a compound of formula 107.
상기 식에서,Where
a는 1 내지 16이고, b는 1 또는 2이며,a is 1 to 16, b is 1 or 2,
c는 1 내지 14이고, n은 0 또는 1이며,c is 1 to 14, n is 0 or 1,
고리 A 및 B는 각각 독립적으로 시클로헥실, 비치환된 페닐, 모노플루오로페닐, 디플루오로페닐, 디옥사닐, 피리미딜 및 피리디닐로 구성되는 군으로부터 선택되고,Rings A and B are each independently selected from the group consisting of cyclohexyl, unsubstituted phenyl, monofluorophenyl, difluorophenyl, dioxanyl, pyrimidyl and pyridinyl,
R은 C1-6알킬이며,R is C 1-6 alkyl,
X는 H 또는 F이고,X is H or F,
B는 차단기이다.B is a breaker.
차단기 B는 특별히 제한되지 않고, 적당하게 당업자에 의해 선택될 수 있다. 적절한 차단기의 예로는 문헌 (T.H. Greene 및 P.G.M. Wuts 'Protective Groups in Organic Synthesis', 2nd Edition, 1991, John Wiley)에 기재되어 있는 것, 예를 들어 메톡시카르보닐, 벤질 및 테트라히드로피라닐이 포함된다.The breaker B is not particularly limited and may be appropriately selected by those skilled in the art. Examples of suitable blockers include those described in TH Greene and PGM Wuts' Protective Groups in Organic Synthesis, 2nd Edition, 1991, John Wiley, for example methoxycarbonyl, benzyl and tetrahydropyranyl do.
상기는 바람직한 방법을 나타내지만, 상이한 순서로 동일한 변형을 행할 수 있다는 것이 이해될 것이다. 예를 들어, 제1 단계에서 화학식 107e의 화합물 및 B가 H이고 CO2H가 적절하게 차단된 화학식 107c의 화합물과 유사한 화합물 사이의 에스테르 결합을 형성할 수 있다. 본 발명의 방법은 화학식 107a, 107c 및 107e의 화합물과 유사한 화합물이 결합되고 변형되어 화학식 107의 화합물을 얻을 수 있는 다른 유사한 변형을 포함하도록 의도된다.While the above represents a preferred method, it will be appreciated that the same modifications can be made in different orders. For example, in the first step, an ester bond can be formed between a compound of formula 107e and a compound similar to the compound of formula 107c wherein B is H and CO 2 H is suitably blocked. The method of the present invention is intended to include other similar modifications in which compounds similar to the compounds of Formulas 107a, 107c and 107e can be combined and modified to obtain compounds of Formula 107.
본 발명은 하기 화학식 107의 화합물의 제조 방법을 제공하며, 상기 방법은 하기 화학식 108의 화합물을 하기 화학식 109의 화합물과 반응시키는 단계를 포함한다.The present invention provides a method for preparing a compound of Formula 107, which method comprises reacting a compound of Formula 108 with a compound of Formula 109.
<화학식 107><Formula 107>
상기 식에서, 고리 A, 고리 B, a, b, c, n 및 X는 상기 정의된 바와 같다.Wherein ring A, ring B, a, b, c, n and X are as defined above.
또한, 본 발명은 하기 화학식 106a의 화합물의 제조 방법을 제공하며, 상기 방법은 하기 화학식 110의 화합물을 하기 화학식 111 또는 화학식 112의 화합물과 반응시키는 단계를 포함한다.In addition, the present invention provides a method for preparing a compound of Formula 106a, which comprises reacting a compound of Formula 110 with a compound of Formula 111 or 112.
상기 식에서,Where
a는 1 내지 16이고,a is 1 to 16,
b는 1 또는 2이며,b is 1 or 2,
c는 1 내지 14이고,c is 1 to 14,
n은 0 또는 1이며,n is 0 or 1,
고리 A 및 B는 각각 독립적으로 시클로헥실, 비치환된 페닐, 모노플루오로페닐, 디플루오로페닐, 디옥사닐, 피리미딜 및 피리디닐로 구성되는 군으로부터 선택되고,Rings A and B are each independently selected from the group consisting of cyclohexyl, unsubstituted phenyl, monofluorophenyl, difluorophenyl, dioxanyl, pyrimidyl and pyridinyl,
X는 H 또는 F이며,X is H or F,
Z는 CO2또는 O이고,Z is CO 2 or O,
(*)는 비대칭 탄소 원자를 나타낸다.(*) Represents an asymmetric carbon atom.
상기 식에서, Tf는 트리플루오로메틸술포닐을 나타낸다.In the formula, Tf represents trifluoromethylsulfonyl.
본 발명의 제4면은 그 중 1종 이상이 키랄 스멕틱 CA(SA) 상을 나타내는 화학식 106의 화합물로부터 선택되는 1종 이상의 화합물을 포함하는 반강유전성 액정 조성물을 제공한다.A fourth aspect of the present invention provides a semiferroelectric liquid crystal composition comprising at least one compound selected from the compounds of the formula 106 in which at least one of them exhibits a chiral smectic C A (S A ) phase.
본 발명의 실시태양은 첨부되는 도면을 참고로 예로서 기재된다. 본 실시예에서 사용된 용어 'biph' 또는 'bipheny'은 '비페닐'을 의미하며, 'benz' 또는 'benzoate'는 '벤조에이트'를 의미한다.Embodiments of the present invention are described by way of example with reference to the accompanying drawings. As used herein, the term 'biph' or 'bipheny' means 'biphenyl' and 'benz' or 'benzoate' means 'benzoate'.
<실시예 1 내지 6><Examples 1 to 6>
반응식 1은 화학식 106의 화합물 8a 내지 8f를 얻는데 사용된 합성 경로를 요약한 것이다. 하기 반응 조건은 실시예 1만을 참조하여 기재한 것이나, 유사한 조건이 실시예 2 내지 6을 얻는데 사용되었음을 이해해야 할 것이다.Scheme 1 summarizes the synthetic route used to obtain compounds 8a-8f of Formula 106. The following reaction conditions are described with reference only to Example 1, but it will be understood that similar conditions were used to obtain Examples 2-6.
메틸 (R)-3-벤질옥시부티레이트 (화합물 2)Methyl (R) -3-benzyloxybutyrate (Compound 2)
트리플루오로메탄술폰산 1.0 ㎤를 건조 질소 분위기하에 실온에서 (R)-3-메틸 히드록시부티레이트 (1) 9.20 (77.9 밀리몰), 벤질 2,2,2-트리클로로아세트이미데이트 23.68 g (93.8 밀리몰), 시클로헥산 104 ㎖ 및 디클로로메탄 52 ㎖의 교반된 혼합물에 고무 마개를 통해 주입하였다. 20분 동안 반응물의 색은 무색에서 황색으로 변하였고, 결국 미분된 침전물이 형성되었다. 반응물을 실온에서 추가로 60분 동안 교반한 후, TLC 분석 (9:1 헥산-에틸아세테이트, 2 Rf=0.36)은 벤질 2,2,2-트리클로로아세트이미데이트가 남아있지 않은 것으로 나타났다. 침전물 (트리클로로아세트아미드)를 여과 제거하고, 여액을 포화 탄산수소나트륨 100 ㎖, 물 2×100 ㎖로 순서대로 세척하고, MgSO4상에서 건조시키고, 진공하에 여과하고 증발시켜 투명한 황색 오일을 얻었다. 이를 플래쉬 크로마토그래피 (미세 메쉬 실리카겔; 9.2:0.8 헥산-에틸아세테이트)로 정제하여 연한 황색 오일을 얻고, 이를 진공하에 건조시켰다 (P2O5, 10mbar, 실온, 72시간). 수율: 13.40 (82).9.3 (77.9 mmol) of (R) -3-methyl hydroxybutyrate (1), 23.68 g (93.8 mmol) of benzyl 2,2,2-trichloroacetimimate at room temperature under a dry nitrogen atmosphere at ), 104 mL of cyclohexane and 52 mL of dichloromethane were injected via a rubber stopper. For 20 minutes the color of the reaction turned from colorless to yellow, eventually forming a fine precipitate. After the reaction was stirred for an additional 60 minutes at room temperature, TLC analysis (9: 1 hexane-ethylacetate, 2 Rf = 0.36) showed no benzyl 2,2,2-trichloroacetimidate remaining. The precipitate (trichloroacetamide) was filtered off and the filtrate was washed sequentially with 100 mL of saturated sodium hydrogen carbonate, 2 x 100 mL of water, dried over MgSO 4 , filtered under vacuum and evaporated to give a clear yellow oil. It was purified by flash chromatography (fine mesh silica gel; 9.2: 0.8 hexanes-ethyl acetate) to give a pale yellow oil which was dried under vacuum (P 2 O 5 , 10 mbar, room temperature, 72 h). Yield: 13.40 (82).
(R)-3-(벤질옥시)부탄-1-올 (화합물 3)(R) -3- (benzyloxy) butan-1-ol (compound 3)
화합물 2 13.0 g (62.5 밀리몰)을 건조 테트라히드로푸란 100 ㎖ 중에 용해시키고, 건조 테트라히드로푸란 100 ㎖ 중에 수소화리튬알루미늄 2.50 g (65.9 밀리몰)의 교반된 현탁액에 적가하고, 반응 온도를 적가하는 동안 10 내지 20℃ 사이로 유지하였다. 첨가를 종결한 후, 반응물을 7℃에서 추가로 1.5 시간 동안 교반하고, 실온으로 밤새 가온되도록 하였다. TLC 분석 (CH2Cl2; Rf 화합물 2=0.30, Rf 화합물 2=0.66)은 출발물질이 남아있지 않는 것으로 나타났다. 에틸아세테이트 30 ㎖, 이어서 물 50 ㎖ 및 10염산 50 ㎖를 적가하였다. 수층을 분리하고, 디에틸에테르 5×100 ㎖로 반복 세척하였다. 한데모은 유기 추출물을 염수 50 ㎖로 세척하고, MgSO4상에서 건조시키고, 여과하고, 증발시켜 연한색 오일을 얻었다. 이를 플래쉬 크로마토그래피[미세 메쉬 실리카겔; 디클로로메탄 (초기) 및 9:1 디클로로메탄-디에틸에테르(최종)]로 정제하여 연한색 오일을 얻고, 이를 진공하에 건조시켰다 (P2O5, 0.1 mbar, 실온, 5 시간). 수율=9.11 g (81).13.0 g (62.5 mmol) of compound 2 are dissolved in 100 ml of dry tetrahydrofuran, and added dropwise to 2.50 g (65.9 mmol) of a suspension of lithium aluminum hydride in 100 ml of dry tetrahydrofuran, and the reaction temperature is added dropwise 10 Kept between 20 ° C. After the addition was complete, the reaction was stirred for an additional 1.5 h at 7 ° C. and allowed to warm to rt overnight. TLC analysis (CH 2 Cl 2 ; Rf compound 2 = 0.30, Rf compound 2 = 0.66) showed no starting material remaining. 30 mL of ethyl acetate was added dropwise followed by 50 mL of water and 50 mL of 10 hydrochloric acid. The aqueous layer was separated and washed repeatedly with 5 x 100 mL of diethyl ether. HANDemo silver organic extracts were washed with 50 mL brine, dried over MgSO 4 , filtered and evaporated to give a light oil. Flash chromatography [micro mesh silica gel; Dichloromethane (initial) and 9: 1 dichloromethane-diethylether (final)] to give a light oil that is dried under vacuum (P 2 O 5 , 0.1 mbar, room temperature, 5 hours). Yield = 9.11 g (81).
(R)-3-(벤질옥시)-1-메톡시부탄 (화합물 4a)(R) -3- (benzyloxy) -1-methoxybutane (Compound 4a)
건조 디메틸포름아미드 20 ㎖ 중의 메틸요오디드 1.59 g (11.2 밀리몰)를 건조 질소 분위기하에 실온에서 건조 디메틸포름아미드 20 ㎖ 중에서 수소화나트륨 0.68 g (60분산물) 및 화합물 3 1.80 g (10.0 밀리몰)의 교반된 현탁액에 적가하였다. 반응물을 약 48시간 동안 교반하고, 물 30 ㎖를 조심스럽게 가하여 과잉의 수소화나트륨을 파괴시켰다. 반응 혼합물을 디클로로메탄 100 ㎖로 희석하고, 유기상을 분리하였다. 수상을 디클로로메탄 3×50 ㎖로 세척하였다. 한데모은 유기 추출물을 10염산 50 ㎖, 포화 탄산수소나트륨 50 ㎖ 및 염수 50 ㎖의 순서로 세척하고, MgSO4상에서 건조시키고, 여과하고, 증발시켜 황색 오일을 얻었다. 이를 플래쉬 크로마토그래피 (미세 메쉬 실리카겔; 헥산 중 4(v/v) 에틸아세테이트)로 정제하여 무색 액체를 얻고, 이를 진공하에 건조시켰다. 수율=1.49 g (76).1.59 g (11.2 mmol) of methyliodide in 20 mL of dry dimethylformamide are stirred at 20 ° C. in dry dimethylformamide at room temperature under stirring of 0.68 g (60 dispersions) of sodium hydride and 1.80 g (10.0 mmol) of compound 3 To the prepared suspension. The reaction was stirred for about 48 hours and 30 ml of water was carefully added to destroy excess sodium hydride. The reaction mixture was diluted with 100 mL dichloromethane and the organic phase was separated. The aqueous phase was washed with 3 x 50 mL of dichloromethane. HANDemo silver organic extract was washed in the order of 50 ml of 10 hydrochloric acid, 50 ml of saturated sodium bicarbonate and 50 ml of brine, dried over MgSO 4 , filtered and evaporated to give a yellow oil. It was purified by flash chromatography (fine mesh silica gel; 4 (v / v) ethyl acetate in hexane) to give a colorless liquid which was dried under vacuum. Yield = 1.49 g (76).
(R)-3-(벤질옥시)-1-에톡시부탄 (화합물 4b)(R) -3- (benzyloxy) -1-ethoxybutane (Compound 4b)
수율 1.32 g (63).Yield 1.32 g (63).
(R)-3-(벤질옥시)-1-부톡시부탄 (화합물 4c)(R) -3- (benzyloxy) -1-butoxybutane (Compound 4c)
수율 1.33 g (56).Yield 1.33 g (56).
(R)-3-(벤질옥시)-1-펜톡시부탄 (화합물 4d)(R) -3- (benzyloxy) -1-pentoxybutane (Compound 4d)
수율 0.99 g (51).Yield 0.99 g (51).
(R)-3-(벤질옥시)-1-도데실옥시부탄 (화합물 4e)(R) -3- (benzyloxy) -1-dodecyloxybutane (Compound 4e)
수율 2.07 g (53).Yield 2.07 g (53).
(R)-3-벤질옥시-1-테트라데실옥시부탄 (화합물 4f)(R) -3-benzyloxy-1-tetradecyloxybutane (Compound 4f)
수율=3.09 gYield = 3.09 g
(R)-4-메톡시부탄-2-올 (화합물 5a)(R) -4-methoxybutan-2-ol (compound 5a)
화합물 4a 1.42 g (7.3 밀리몰)을 에탄올 58 ㎖ 및 시클로헥센 30 ㎖ 중에 용해시키고, 흑연 상의 팔라듐 수산화물 0.22 g (20수분 분산도)을 가하였다. 생성된 현탁액을 환류하에(약 90℃) 6시간 동안 가열하였다. 반응 혼합물의 GC 분석은 출발 물질 4a가 남아있지 않는 것으로 나타났다(GC 조건은 주입 220℃, 검출 300℃, 오븐 80℃에서 1분 유지, 분당 30℃씩 250℃까지 증가시켜 2분 유지, Rf 4a=6.76분, Rf 5a=2.17분임). 냉각된 반응 혼합물을 하이플로-수퍼셀(Hyflo-Supercel) (등록상표)의 패드를 통해 여과하고, 여액을 증발시켜 모든 용매를 제거하여 무색 액체를 얻고, 원한다면 추가로 쿠겔로 (Kugelrohr) 증류에 의해 정제할수 있다. 생성물을 진공하에 건조시켰다 (P2O5, 10 mbar, 실온, 18시간). 수율=0.47 g (62).1.42 g (7.3 mmol) of compound 4a were dissolved in 58 ml of ethanol and 30 ml of cyclohexene, and 0.22 g of palladium hydroxide on graphite (20 minutes dispersion) was added. The resulting suspension was heated at reflux (about 90 ° C.) for 6 hours. GC analysis of the reaction mixture showed no starting material 4a remaining (GC conditions were maintained at injection 220 ° C., detection 300 ° C., oven 80 ° C. for 1 minute, increase to 30 ° C. per minute to 250 ° C., Rf 4a = 6.76 min, Rf 5a = 2.17 min). The cooled reaction mixture is filtered through a pad of Hyflo-Supercel® and the filtrate is evaporated to remove all solvents to give a colorless liquid, further optionally with Kugelrohr distillation. Can be purified by The product was dried under vacuum (P 2 O 5 , 10 mbar, room temperature, 18 h). Yield = 0.47 g (62).
(R)-4-에톡시부탄-2-올 (화합물 5b)(R) -4-ethoxybutan-2-ol (Compound 5b)
수율=0.58 g (82).Yield = 0.58 g (82).
(R)-4-부톡시부탄-2-올 (화합물 5c)(R) -4-butoxybutan-2-ol (Compound 5c)
수율=0.46 g (61).Yield = 0.46 g (61).
(R)-4-펜톡시부탄-2-올 (화합물 5d)(R) -4-pentoxybutan-2-ol (compound 5d)
수율=0.46 g (92).Yield = 0.46 g (92).
(R)-4-도데실옥시부탄-2-올 (화합물 5e)(R) -4-dodecyloxybutan-2-ol (compound 5e)
수율=1.47 g (100).Yield = 1.47 g (100).
(R)-4-테트라데실옥시부탄-2-올 (화합물 5f)(R) -4-tetradecyloxybutan-2-ol (compound 5f)
수율=2.28 g (100).Yield = 2.28 g (100).
(S)-2-(4-메톡시)부틸 4-메톡시카르보닐옥시벤조에이트 (화합물 6a)(S) -2- (4-methoxy) butyl 4-methoxycarbonyloxybenzoate (Compound 6a)
건조 테트라히드로푸란 20 ㎖ 중의 화합물 5a 0.44 g (4.2 밀리몰), 트리페닐포스핀 0.73 g (2.8 밀리몰)의 용액을 건조 질소 분위기하에 실온에서 건조 테트라히드로푸란 15 ㎖ 중의 디에틸 아조디카르복실레이트 0.50 g (2.8 밀리몰) 및 4-메톡시카르보닐옥시벤조산 0.55 g (2.8 밀리몰)의 교반된 용액에 적가하였다. 황색의 반응 혼합물을 약 10분 동안 배출하고, 반응 혼합물을 추가로 18시간 동안 교반되도록 방치하였다. 반응 혼합물을 디에틸에테르 150 ㎖로 희석하고, 하이플로-수퍼셀 (등록상표)의 패드를 통해 여과하고, 여액을 염수 50 ㎖로 세척하고, MgSO4상에서 건조시키고, 여과하고, 증발시켜 무색 오일을 얻었다. 이를 플래쉬 크로마토그래피[미세 메쉬 실라케겔; 9:1 디클로로메탄-에틸아세테이트]로 정제하여 무색 오일을 얻고, 이를 진공하에 건조시켰다 (P2O5, 10 mbar, 실온, 5시간). 수율=0.49 g (62).A solution of 0.44 g (4.2 mmol) of compound 5a and 0.73 g (2.8 mmol) of triphenylphosphine in 20 ml of dry tetrahydrofuran was dried at room temperature under a dry nitrogen atmosphere at 0.50 diethyl azodicarboxylate in 15 ml of tetrahydrofuran. g (2.8 mmol) and 0.55 g (2.8 mmol) of 4-methoxycarbonyloxybenzoic acid were added dropwise. The yellow reaction mixture was drained for about 10 minutes and the reaction mixture was left to stir for an additional 18 hours. The reaction mixture is diluted with 150 ml of diethyl ether, filtered through a pad of Hyflo-Supercell®, the filtrate is washed with 50 ml of brine, dried over MgSO 4 , filtered and evaporated to a colorless oil. Got. This was followed by flash chromatography [micro mesh silica gel; 9: 1 dichloromethane-ethyl acetate] to give a colorless oil which was dried under vacuum (P 2 O 5 , 10 mbar, room temperature, 5 h). Yield = 0.49 g (62).
(S)-2-(4-에톡시)부틸 4-메톡시카르보닐옥시벤조에이트 (화합물 6b)(S) -2- (4-ethoxy) butyl 4-methoxycarbonyloxybenzoate (Compound 6b)
수율=0.68 g (67).Yield = 0.68 g (67).
(S)-2-(4-부톡시)부틸 4-메톡시카르보닐옥시벤조에이트 (화합물 6c)(S) -2- (4-butoxy) butyl 4-methoxycarbonyloxybenzoate (Compound 6c)
수율=0.44 g (44).Yield = 0.44 g (44).
(S)-2-(4-펜톡시)부틸 4-메톡시카르보닐옥시벤조에이트 (화합물 6d)(S) -2- (4-pentoxy) butyl 4-methoxycarbonyloxybenzoate (Compound 6d)
수율=0.45 g (73).Yield = 0.45 g (73).
(S)-2-(4-도데실옥시)부틸 4-메톡시카르보닐옥시벤조에이트 (화합물 6e)(S) -2- (4-dodecyloxy) butyl 4-methoxycarbonyloxybenzoate (Compound 6e)
수율=1.10 g (66).Yield = 1.10 g (66).
(S)-2-(4-테트라데실옥시)부틸 4-메톡시카르보닐옥시벤조에이트 (화합물 6f)(S) -2- (4-tetradecyloxy) butyl 4-methoxycarbonyloxybenzoate (Compound 6f)
수율=1.86 g (76).Yield = 1.86 g (76).
(S)-2-(4-메톡시)부틸 4-히드록시벤조에이트 (화합물 7a)(S) -2- (4-methoxy) butyl 4-hydroxybenzoate (Compound 7a)
화합물 6a 0.39 g (1.4 밀리몰)을 에탄올 15 ㎖ 중에 용해시키고, 암모니아 7.0 ㎖ (비중 0.88)를 실온에서 교반하면서 적가하였다. 반응물을 추가로 48시간 동안 교반되도록 방치하였다. TLC 분석 (디클로로메탄)은 출발물질이 남아있지 않는 것으로 나타났다. 반응물을 교반하면서 물 100 ㎖에 부어넣고, 추출된 생성물을 디에틸에테르 4×50 ㎖로 세척하였다. 한데모은 에테르성 추출물을 물 20 ㎖로 세척한 후, MgSO4상에서 건조시키고, 여과하고, 증발시켜 무색 오일을 얻고, 진공하에 건조시켰다 (P2O5, 10 mbar, 실온, 4시간). 수율=0.31 g (100).0.39 g (1.4 mmol) of compound 6a was dissolved in 15 mL of ethanol, and 7.0 mL (specific gravity 0.88) of ammonia was added dropwise while stirring at room temperature. The reaction was left to stir for an additional 48 hours. TLC analysis (dichloromethane) showed no starting material remaining. The reaction was poured into 100 mL of water with stirring and the extracted product was washed with 4 x 50 mL of diethyl ether. Handemo was washed with 20 ml of ethereal extract, dried over MgSO 4 , filtered and evaporated to give a colorless oil and dried under vacuum (P 2 O 5 , 10 mbar, room temperature, 4 hours). Yield = 0.31 g (100).
(S)-2-(4-에톡시)부틸-4-히드록시벤조에이트 (화합물 7b)(S) -2- (4-ethoxy) butyl-4-hydroxybenzoate (Compound 7b)
수율=0.50 g (100).Yield = 0.50 g (100).
(S)-2-(4-부톡시)부틸-4-히드록시벤조에이트 (화합물 7c)(S) -2- (4-butoxy) butyl-4-hydroxybenzoate (Compound 7c)
수율=0.35 g (100).Yield = 0.35 g (100).
(S)-2-(4-펜톡시)부틸-4-히드록시벤조에이트 (화합물 7d)(S) -2- (4-pentoxy) butyl-4-hydroxybenzoate (Compound 7d)
수율=0.24 g (72).Yield = 0.24 g (72).
(S)-2-(4-도데실옥시)부틸-4-히드록시벤조에이트 (화합물 7e)(S) -2- (4-dodecyloxy) butyl-4-hydroxybenzoate (Compound 7e)
수율=0.95 g (100).Yield = 0.95 g (100).
(S)-2-(4-테트라데실옥시)부틸-4-히드록시벤조에이트 (화합물 7f)(S) -2- (4-tetradecyloxy) butyl-4-hydroxybenzoate (Compound 7f)
수율=0.48 g (92).Yield = 0.48 g (92).
<실시예 1><Example 1>
(S)-2-(4-메톡시)부틸 4-(4'-도데실옥시비페닐-4-일카르보닐옥시)벤조에이트 (화합물 8a)(S) -2- (4-methoxy) butyl 4- (4'-dodecyloxybiphenyl-4-ylcarbonyloxy) benzoate (Compound 8a)
1,3-디시클로헥실카르보디이미드 0.31 g (1.50 밀리몰)을 실온에서 건조 테트라히드로푸란 30 ㎖ 중의 4'-도데실옥시비페닐-4-카르복실산, 화합물 7a 0.23 g (0.82 밀리몰), 4-N,N-디메틸아미노피리딘 0.02 g (0.16 밀리몰)의 교반된 혼합물에 가하였다. TLC 분석이 추가의 반응을 보이지 않을 때까지, 반응물을 24시간 동안 교반되도록 방치하였다. 반응 혼합물을 디클로로메탄 200 ㎖로 희석하고, 1,3-디시클로헥실우레아의 불용성 침전물을 하이플로-수퍼셀 (등록상표)의 패드를 통해 여과하여 제거하였다. 여액을 물 50 ㎖, 10(v/v) 아세트산 2×50 ㎖, 물 50 ㎖의 순서로 세척하고, MgSO4상에서 건조시키고, 여과하고, 증발시켜 무색 고체를 얻었다. 이를 플래쉬 크로마토그래피[미세 메쉬 실리카겔; 9:1 헥산-에틸아세테이트]; 재결정(헥산×4)하여 정제하고, 진공하에 건조시켰다 (P2O5, 0.2 mbar, 40℃, 18시간). 수율=0.16 g (11).0.31 g (1.50 mmol) of 1,3-dicyclohexylcarbodiimide was dried at room temperature 4'-dodecyloxybiphenyl-4-carboxylic acid in 30 mL tetrahydrofuran, 0.23 g (0.82 mmol) of a compound 7a, 4 0.02 g (0.16 mmol) of -N, N-dimethylaminopyridine was added to the stirred mixture. The reaction was left to stir for 24 hours until TLC analysis showed no further reaction. The reaction mixture was diluted with 200 mL of dichloromethane and the insoluble precipitate of 1,3-dicyclohexylurea was removed by filtration through a pad of Hyflo-Supercell®. The filtrate was washed in the order of 50 mL of water, 2 × 50 mL of 10 (v / v) acetic acid, 50 mL of water, dried over MgSO 4 , filtered and evaporated to give a colorless solid. Flash chromatography [micro mesh silica gel; 9: 1 hexane-ethyl acetate]; Purified by recrystallization (hexane × 4) and dried under vacuum (P 2 O 5 , 0.2 mbar, 40 ° C., 18 h). Yield = 0.16 g (11).
<실시예 2><Example 2>
(S)-2-(4-에톡시)부틸 4-(4'-도데실옥시비페닐-4-일카르보닐옥시)벤조에이트 (화합물 8b)(S) -2- (4-ethoxy) butyl 4- (4'-dodecyloxybiphenyl-4-ylcarbonyloxy) benzoate (Compound 8b)
상기 화합물을 플래쉬 크로마토그래피 [미세 메쉬 실리카겔; 헥산 중 15(v/v) 에틸아세테이트 (×3)]로 정제하여 무색 고체를 얻었다. 이를 재결정 (에탄올×5, 아세토니트릴×2)하고, 진공하에 건조시켰다 (P2O5, 5.0 mbar, 40℃, 18시간). 수율=0.24 g (20).Flash chromatography of the compound [micro mesh silica gel; 15 (v / v) ethyl acetate (x3) in hexanes] gave a colorless solid. It was recrystallized (ethanol × 5, acetonitrile × 2) and dried under vacuum (P 2 O 5 , 5.0 mbar, 40 ° C., 18 hours). Yield = 0.24 g (20).
<실시예 3><Example 3>
(S)-2-(4-부톡시)부틸 4-(4'-도데실옥시비페닐-4-일카르보닐옥시)벤조에이트 (화합물 8c)(S) -2- (4-butoxy) butyl 4- (4'-dodecyloxybiphenyl-4-ylcarbonyloxy) benzoate (Compound 8c)
상기 화합물을 플래쉬 크로마토그래피 [미세 메쉬 실리카겔; 헥산 중 10(v/v) 에틸아세테이트]로 정제하여 무색 고체를 얻었다. 이를 재결정(에탄올×5, 헥산×3)하고, 진공하에 건조시켰다 (P2O5, 1.0 mbar, 40℃, 8시간). 수율=0.29 g (51).Flash chromatography of the compound [micro mesh silica gel; 10 (v / v) ethyl acetate in hexane] afforded a colorless solid. It was recrystallized (ethanol × 5, hexane × 3) and dried under vacuum (P 2 O 5 , 1.0 mbar, 40 ° C., 8 hours). Yield = 0.29 g (51).
<실시예 4><Example 4>
(S)-2-(4-펜톡시)부틸 4-(4'-도데실옥시비페닐-4-일카르보닐옥시)벤조에이트 (화합물 8d)(S) -2- (4-pentoxy) butyl 4- (4'-dodecyloxybiphenyl-4-ylcarbonyloxy) benzoate (Compound 8d)
상기 화합물을 플래쉬 크로마토그래피 [미세 메쉬 실리카겔; 헥산 중 12(v/v) 에틸아세테이트]로 정제하여 무색 고체를 얻고, 이를 재결정하였다 (에탄올×3, 헥산×3). 수율=0.26 g (50).Flash chromatography of the compound [micro mesh silica gel; 12 (v / v) ethyl acetate in hexane] afforded a colorless solid which was recrystallized (ethanol × 3, hexane × 3). Yield = 0.26 g (50).
<실시예 5>Example 5
(S)-2-(4-도데실옥시)부틸 4-(4'-도데실옥시비페닐-4-일카르보닐옥시)벤조에이트 (화합물 8e)(S) -2- (4-dodecyloxy) butyl 4- (4'-dodecyloxybiphenyl-4-ylcarbonyloxy) benzoate (Compound 8e)
상기 화합물을 플래쉬 크로마토그래피 [미세 메쉬 실리카겔; 헥산 중 13(v/v) 에틸아세테이트, 9:1 디클로로메탄-헥산]로 정제하여 무색 고체를 얻었다. 이를 재결정하였다 (에탄올-에틸아세테이트×4). 수율=0.88 g (47).Flash chromatography of the compound [micro mesh silica gel; 13 (v / v) ethyl acetate in hexane, 9: 1 dichloromethane-hexane] to give a colorless solid. It was recrystallized (ethanol-ethyl acetate x 4). Yield = 0.88 g (47).
<실시예 6><Example 6>
(S)-2-(4-테트라데실옥시)부틸 4-(4'-도데실옥시비페닐-4-일카르보닐옥시)벤조에이트 (화합물 8f)(S) -2- (4-tetradecyloxy) butyl 4- (4'-dodecyloxybiphenyl-4-ylcarbonyloxy) benzoate (Compound 8f)
상기 화합물을 플래쉬 크로마토그래피 [미세 메쉬 실리카겔; 헥산 중 13(v/v) 에틸아세테이트, 9:1 디클로로메탄-헥산]로 정제하여 무색 고체를 얻었다.이를 재결정하였다 (에탄올-에틸아세테이트×4). 수율=0.46 g (53).Flash chromatography of the compound [micro mesh silica gel; 13 (v / v) ethyl acetate in hexanes, 9: 1 dichloromethane-hexane] to give a colorless solid. This was recrystallized (ethanol-ethyl acetate x 4). Yield = 0.46 g (53).
<실시예 7><Example 7>
반응식 2는 화학식 16을 얻는데 사용될 수 있는 합성 경로를 요약한 것이다. 하기 반응 조건은 실시예 1 내지 6에서 기재된 것과 유사하다.Scheme 2 summarizes the synthetic routes that can be used to obtain Formula 16. The following reaction conditions are similar to those described in Examples 1-6.
(R)-3-메틸벤질옥시펜타노에이트 (화합물 10)(R) -3-methylbenzyloxypentanoate (Compound 10)
화합물 9, (-)-메틸 (R)-3-히드록시발러레이트를 출발 물질로 사용하여 화합물 2에 대해 기재된 것과 유사한 방법을 사용하였다. 플래쉬 크로마토그래피한 후에 얻은 오일을 쿠겔로 증류 (1.0 mbar, 140℃)에 의해 추가로 정제하였다. 수율=5.97 g (70).A method similar to that described for compound 2 was used using compound 9, (-)-methyl (R) -3-hydroxyvalerate as starting material. The oil obtained after flash chromatography was further purified by distillation with cogel (1.0 mbar, 140 ° C.). Yield = 5.97 g (70).
(R)-3-(벤질옥시)펜탄-1-올 (화합물 11)(R) -3- (benzyloxy) pentan-1-ol (compound 11)
화합물 10을 출발 물질로 사용하여 화합물 3에 대해 기재된 것과 유사한 방법을 사용하여 합성하였다. 플래쉬 크로마토그래피 후에 얻은 오일을 쿠겔로 증류(1.0 mbar, 160℃]에 의해 추가로 정제하였다. 수율=4.03g (79).Compound 10 was synthesized using a method analogous to that described for compound 3 using starting material. The oil obtained after flash chromatography was further purified by distillation with cogel (1.0 mbar, 160 ° C.) Yield = 4.03 g (79).
(R)-3-벤질옥시-1-도데실옥시펜탄 (화합물 12)(R) -3-benzyloxy-1-dodecyloxypentane (Compound 12)
화합물 4a 내지 4f에 대해 기재된 방법을 사용하여 합성하였다. 수율=2.56 g (80).Synthesis was carried out using the method described for compounds 4a to 4f. Yield = 2.56 g (80).
(R)-5-도데실옥시펜탄-3-올 (화합물 13)(R) -5-dodecyloxypentan-3-ol (compound 13)
화합물 5a 내지 5f에 대해 기재된 방법을 사용하여 합성하였다. 수율=1.82 g (96).Synthesis was carried out using the method described for compounds 5a to 5f. Yield = 1.82 g (96).
(R)-3-(5-도데실옥시)펜틸 4-메톡시카르보닐옥시벤조에이트 (화합물 14)(R) -3- (5-dodecyloxy) pentyl 4-methoxycarbonyloxybenzoate (Compound 14)
화합물 6a 내지 6f에 대해 기재된 방법을 사용하여 합성하였다. 수율=0.65g (33).Synthesis was carried out using the method described for compounds 6a to 6f. Yield = 0.65 g (33).
(R)-3-(5-도데실옥시)펜틸 4-히드록시벤조에이트 (화합물 15)(R) -3- (5-dodecyloxy) pentyl 4-hydroxybenzoate (Compound 15)
화합물 7a 내지 7f에 대해 기재된 방법을 사용하여 합성하였다. 수율=0.54g (67).Synthesis was carried out using the method described for compounds 7a to 7f. Yield = 0.54 g (67).
(R)-3-(5-도데실옥시)펜틸 4-(4'-도데실옥시비페닐-4-카르보닐옥시)벤조에이트 (화합물 16)(R) -3- (5-dodecyloxy) pentyl 4- (4'-dodecyloxybiphenyl-4-carbonyloxy) benzoate (Compound 16)
화합물 8a 내지 8f에 대해 기재된 방법을 사용하여 합성하였다. 수율=0.49g (41).Synthesis was carried out using the method described for compounds 8a to 8f. Yield = 0.49 g (41).
실시예 1 내지 8의 상 전이 온도 (℃) 및 엔탈피 (사각 괄호에 표시됨)를 하기 표 1에 기재하였다. 실시예 8은 각 화합물 8a 내지 8d를 1:1:1:1 중량/중량의 혼합물로 포함하는 액정 조성물이다.The phase transition temperatures (° C.) and enthalpy (shown in square brackets) of Examples 1 to 8 are listed in Table 1 below. Example 8 is a liquid crystal composition comprising each compound 8a to 8d in a mixture of 1: 1: 1: 1 weight / weight.
본 명세서에서 보고된 모든 상 전이는 에난티오토픽(enantiotopic)으로서, 즉 상이 가열 및 냉각 시에 관찰되는 것이다. 상 전이 온도는 냉각에 관한 것이다.All phase transitions reported herein are enantiotopics, ie the phases are observed upon heating and cooling. Phase transition temperature relates to cooling.
광학 현미경 및 10℃/분의 가열 및 냉각 속도로 시차 주사 열량계 (DSC)를 병용하여 상 전이 온도를 기록하였다. 시차 주사 열량계를 인듐 표준물 (융점: 156.60℃ 및 ΔH=28.45 J/g)을 사용하여 예비표정하였다.The phase transition temperature was recorded using a differential scanning calorimeter (DSC) in combination with an optical microscope and a heating and cooling rate of 10 ° C./min. Differential scanning calorimetry was pre-marked using an indium standard (melting point: 156.60 ° C. and ΔH = 28.45 J / g).
표 2는 실시예 1 내지 6 및 실시예 8의 스위칭 특성을 나타내고 있다.Table 2 shows the switching characteristics of Examples 1 to 6 and Example 8.
하기 반응식 3 및 4는 하기 실시예 9에서 언급된 추가의 화합물에 대한 합성 경로를 제공한다.Schemes 3 and 4 below provide synthetic routes to the additional compounds mentioned in Example 9 below.
<실시예 9>Example 9
일련의 5개의 모노 플루오로 치환된 물질을 합성하고, 구조 및 최종 단계는 반응식 4에 나타내었다. 1,3-N,N-디시클로헥실 카르보디이미드 (DCC) 및 4-N,N-디메틸아미노피리딘 (DMAP)를 사용하여, 물질을 적절히 치환된 비페닐 카르복실산 (화합물 7a, 22-25)를 키랄 벤조에이트 에스테르 (화합물 7d 또는 21)로 에스테르화하여 제조하였다. 모노 플루오로 치환된 카르복실산을 알킬화, 팔라듐(0) 촉매화된 교차 커플링, 시안화, 가수분해 및 카르복실화 반응을 비롯한 다양한 방법을 사용하여 제조하였다. 반응식 3은 (S)-2-(4-펜톡시)부틸 4-히드록시-3-플루오로벤조에이트 (21)의 합성을 개략적으로 나타내고 있다.A series of five mono fluoro substituted materials were synthesized and the structure and final steps are shown in Scheme 4. Using 1,3-N, N-dicyclohexyl carbodiimide (DCC) and 4-N, N-dimethylaminopyridine (DMAP), the material was suitably substituted biphenyl carboxylic acid (compounds 7a, 22- 25) was prepared by esterification with a chiral benzoate ester (Compound 7d or 21). Mono fluoro substituted carboxylic acids were prepared using a variety of methods including alkylation, palladium (0) catalyzed cross coupling, cyanation, hydrolysis and carboxylation reactions. Scheme 3 schematically shows the synthesis of (S) -2- (4-pentoxy) butyl 4-hydroxy-3-fluorobenzoate (21).
4-벤질옥시-3-플루오로벤조산 (18)4-Benzyloxy-3-fluorobenzoic acid (18)
부틸리튬 6.0 ㎖ (헥산 중 10.0 M, 약 54 밀리몰)을 주사기를 통하여 건조 질소 분위기하에서 건조 테트라히드로푸란 200 ㎖ 중의 1-브로모-4-벤질옥시-3-플루오로벤젠 (17) 15.05 g (53.6 밀리몰)의 -78℃로 냉각되고 교반된 용액에 적가하였다. 적가하는 동안 온도는 -70℃를 초과하지 않았고, 부틸리튬을 가하는 동안 무색 용액이 연황색으로 변하였다. 첨가를 종결한 후, 반응물을 -78℃에서 3시간 더 교반되도록 하고, 고체 이산화탄소 (약 50 g) 및 건조 테트라히드로푸란 20 ㎖의 슬러리에 부었다. 생성된 슬러리를 격렬히 교반하면서 실온으로 가온되도록 하였고, 진한 염산을 적가하여 산성화하였다. 물 200 ㎖를 가하고, 디에틸에테르 3×100 ㎖를 사용하여 생성물을 추출하였다. 한데모은 에테르층을 염수로 세척하고, MgSO4상에서 건조시키고, 여과하고, 증발시켜 회백색 고체를 얻었다. 재결정하고(헥산-에틸아세테이트), 진공 중에 건조시켰다(P2O5, 1.0 mbar, 실온, 18시간).수율=7.02 g (53).15.05 g of 1-bromo-4-benzyloxy-3-fluorobenzene (17) in 200 ml of dry tetrahydrofuran under a dry nitrogen atmosphere via 6.0 ml of butyllithium (10.0 M in hexane, about 54 mmol) through a syringe 53.6 mmol) was added dropwise to the cooled and stirred solution. During dropping the temperature did not exceed −70 ° C. and the colorless solution turned pale yellow while butyllithium was added. After the addition was complete, the reaction was allowed to stir for another 3 hours at −78 ° C. and poured into a slurry of 20 ml of solid carbon dioxide (about 50 g) and dry tetrahydrofuran. The resulting slurry was allowed to warm to room temperature with vigorous stirring and acidified by dropwise addition of concentrated hydrochloric acid. 200 ml of water was added, and the product was extracted using 3 * 100 ml of diethyl ether. Handemo ether layer was washed with brine, dried over MgSO 4 , filtered and evaporated to yield an off-white solid. Recrystallized (hexane-ethyl acetate) and dried in vacuo (P 2 O 5 , 1.0 mbar, room temperature, 18 h). Yield = 7.02 g (53).
(S)-2-(4-펜톡시)부틸 4-벤질옥시-3-플루오로벤조에이트 (19)(S) -2- (4-pentoxy) butyl 4-benzyloxy-3-fluorobenzoate (19)
화합물 6a-f와 동일한 방법으로 제조하였다. 플래쉬 크로마토그래피 [미세 메쉬 실리카겔; 헥산(초기), 3에틸아세테이트-헥산(최종)]로 정제하여 무색 액체를 얻었다. 진공 중에서 건조시켰다 (P2O5, 1.0 mbar, 실온, 72시간). 수율=2.68 g(57).Prepared by the same method as the compound 6a-f. Flash chromatography [fine mesh silica gel; Hexane (initial), 3ethyl acetate-hexane (final)] to give a colorless liquid. Dry in vacuo (P 2 O 5 , 1.0 mbar, room temperature, 72 h). Yield = 2.68 g (57).
(S)-2-(4-펜톡시)부틸 4-히드록시-3-플루오로벤조에이트 (20)(S) -2- (4-pentoxy) butyl 4-hydroxy-3-fluorobenzoate (20)
화합물 19 2.62 g (7.0 밀리몰), 석탄상 수산화팔라듐 0.21 g (수분 Pd 20), 시클로헥센 30 ㎖ 및 에탄올 60 ㎖를 교반하면서 7시간 동안 환류하에 가열하였고, 그런 후에 TLC로 남아있는 출발 물질이 없음을 확인하였다. 냉각된 반응 혼합물을디에틸에테르 200 ㎖로 희석하고, 하이플로-수퍼셀의 패드를 통해 여과하고, 여액을 감압하에 증발시켜 연한색 오일을 얻었다. 진공하에 건조시켰다 (P2O5, 1.0 mbar, 실온, 24시간). 수율=1.89 g (90).2.62 g (7.0 mmol) of compound 19, 0.21 g of coal palladium hydroxide (water Pd 20), 30 ml of cyclohexene and 60 ml of ethanol were heated under reflux for 7 hours with stirring, after which no starting material remained in TLC. It was confirmed. The cooled reaction mixture was diluted with 200 mL of diethyl ether, filtered through a pad of Hyflo-Supercell, and the filtrate was evaporated under reduced pressure to give a light oil. Dry under vacuum (P 2 O 5, 1.0 mbar, room temperature, 24 hours). Yield = 1.89 g (90).
(S)-2-(4-펜톡시)부틸 4-(4'-도데실옥시-3'-플루오로비페닐-4-카르보닐옥시)벤조에이트 (26)(S) -2- (4-pentoxy) butyl 4- (4'-dodecyloxy-3'-fluorobiphenyl-4-carbonyloxy) benzoate (26)
플래쉬 크로마토그래피 [미세 메쉬 실리카겔; 헥산 중 12에틸아세테이트 및 미세 메쉬 실리카겔; 6:4 디클로로메탄-헥산]로 2회 정제하여 무색 고체를 얻었다.재결정하고 (에탄올×3), 진공 중에 건조시켰다 (P2O5, 0.5 mbar, 40 ℃, 18시간). 수율=0.66 g (68).Flash chromatography [fine mesh silica gel; 12 ethyl acetate and fine mesh silica gel in hexane; 6: 4 dichloromethane-hexane] to give a colorless solid. Recrystallized (ethanol × 3) and dried in vacuo (P 2 O 5 , 0.5 mbar, 40 ° C., 18 h). Yield = 0.66 g (68).
(S)-2-(4-펜톡시)부틸 4-(4'-도데실옥시-2-플루오로-비페닐-4-카르보닐옥시)벤조에이트 (27)(S) -2- (4-pentoxy) butyl 4- (4'-dodecyloxy-2-fluoro-biphenyl-4-carbonyloxy) benzoate (27)
플래쉬 크로마토그래피 [미세 메쉬 실리카겔; 헥산 중 9에틸아세테이트 및 미세 메쉬 실리카겔; 8:2 디클로로메탄-헥산]로 2회 정제하여 백색 고체를 얻었다. 재결정하고 (에탄올×4), 진공 중에 건조시켰다 (P2O5, 0.5 mbar, 40 ℃, 18시간).수율=0.59 g (59).Flash chromatography [fine mesh silica gel; 9 ethyl acetate and fine mesh silica gel in hexane; 8: 2 dichloromethane-hexane] twice to give a white solid. Recrystallized (ethanol × 4) and dried in vacuo (P 2 O 5 , 0.5 mbar, 40 ° C., 18 h). Yield = 0.59 g (59).
(S)-2-(4-펜톡시)부틸 4-(4'-도데실옥시-2'-플루오로-비페닐-4-카르보닐옥시)벤조에이트 (27)(S) -2- (4-pentoxy) butyl 4- (4'-dodecyloxy-2'-fluoro-biphenyl-4-carbonyloxy) benzoate (27)
플래쉬 크로마토그래피 [미세 메쉬 실리카겔; 헥산 중 9에틸아세테이트 및 미세 메쉬 실리카겔; 7:3 디클로로메탄-헥산]로 2회 정제하여 백색 고체를 얻었다. 재결정하고 (에탄올×4), 진공 중에 건조시켰다 (P2O5, 0.5 mbar, 40 ℃, 24시간). 수율=0.59 g (59).Flash chromatography [fine mesh silica gel; 9 ethyl acetate and fine mesh silica gel in hexane; 7: 3 dichloromethane-hexane] twice to give a white solid. Recrystallized (ethanol × 4) and dried in vacuo (P 2 O 5 , 0.5 mbar, 40 ° C., 24 h). Yield = 0.59 g (59).
(S)-2-(4-펜톡시)부틸 4-(4'-도데실옥시-3-플루오로-비페닐-4-카르보닐옥시)벤조에이트 (29)(S) -2- (4-pentoxy) butyl 4- (4'-dodecyloxy-3-fluoro-biphenyl-4-carbonyloxy) benzoate (29)
플래쉬 크로마토그래피 [미세 메쉬 실리카겔; 10에틸아세테이트-헥산]로 2회 정제하여 백색 고체를 얻었다. 재결정하고 (에탄올×5), 진공 중에 건조시켰다 (P2O5, 0.5 mbar, 30 ℃, 18시간). 수율=0.13 g (30).Flash chromatography [fine mesh silica gel; 10 ethyl acetate-hexane] was purified twice to give a white solid. Recrystallized (ethanol × 5) and dried in vacuo (P 2 O 5 , 0.5 mbar, 30 ° C., 18 h). Yield = 0.13 g (30).
(S)-2-(4-펜톡시)부틸 4-(4'-도데실옥시비페닐-4-카르보닐옥시)-3-플루오로벤조에이트 (30)(S) -2- (4-pentoxy) butyl 4- (4'-dodecyloxybiphenyl-4-carbonyloxy) -3-fluorobenzoate (30)
플래쉬 크로마토그래피 [미세 메쉬 실리카겔; 헥산 중 8에틸아세테이트]로 2회 정제하여 무색 고체를 얻고, 이를 재결정하고 (에탄올×3), 건조시켰다 (P2O5,1.0 mbar, 40 ℃, 18시간). 수율=0.61 g (55).Flash chromatography [fine mesh silica gel; 8 ethyl acetate in hexane] to give a colorless solid which was recrystallized (ethanol × 3) and dried (P 2 O 5 , 1.0 mbar, 40 ° C., 18 h). Yield = 0.61 g (55).
반응식 5는 하기 실시예 10에 기재된 폴리플루오로 치환된 액정 물질에 대한 경로를 나타내고 있다.Scheme 5 shows the route to the polyfluoro substituted liquid crystal material described in Example 10 below.
<실시예 10><Example 10>
하기 폴리플루오로 치환된 물질을 반응식 5에 개략화된 모노 플루오로 치환된 물질 (26-30)에 대해 기재된 것과 유사한 방법으로 제조하였다. 다양한 모노 플루오로 및 디플루오로 치환된 비페닐 카르복실산 (22 및 31)을 다양한 알킬화, 팔라듐(0) 촉매화된 교차 커플링, 시안화, 산 가수분해 및 카르복실화 반응을 통해 제조하였다.The following polyfluoro substituted materials were prepared in a similar manner as described for the mono fluoro substituted materials (26-30) outlined in Scheme 5. Various mono fluoro and difluoro substituted biphenyl carboxylic acids (22 and 31) were prepared via various alkylation, palladium (0) catalyzed cross coupling, cyanation, acid hydrolysis and carboxylation reactions.
(S)-2-(4-펜톡시)부틸 4-(2',3'-디플루오로-4'-옥틸옥시비페닐-4-카르보닐옥시)벤조에이트 (32)(S) -2- (4-pentoxy) butyl 4- (2 ', 3'-difluoro-4'-octyloxybiphenyl-4-carbonyloxy) benzoate (32)
플래쉬 크로마토그래피 [미세 메쉬 실리카겔; 헥산 중 10에틸아세테이트 및미세 메쉬 실리카겔; 6:4 디클로로메탄-헥산 및 미세 메쉬 실리카겔; 8:2 디클로로메탄-헥산]로 3회 정제하여 무색 고체를 얻고, 이를 밀리포어막 필터를 통해 여과하고, 진공 중에 증발 및 건조시켰다 (P2O5, 1.0 mbar, 실온, 45시간). 수율=0.46 g (52).Flash chromatography [fine mesh silica gel; 10 ethyl acetate and fine mesh silica gel in hexanes; 6: 4 dichloromethane-hexane and fine mesh silica gel; 8: 2 dichloromethane-hexane] to give a colorless solid, which was filtered through a Millipore membrane filter, evaporated and dried in vacuo (P 2 O 5 , 1.0 mbar, room temperature, 45 h). Yield = 0.46 g (52).
(S)-2-(4-펜톡시)부틸 4-(4'-도데실옥시-3'-플루오로비페닐-4-카르보닐옥시)-3-플루오로벤조에이트 (33)(S) -2- (4-pentoxy) butyl 4- (4'-dodecyloxy-3'-fluorobiphenyl-4-carbonyloxy) -3-fluorobenzoate (33)
플래쉬 크로마토그래피 [미세 메쉬 실리카겔; 8에틸아세테이트-헥산 및 미세 메쉬 실리카겔; 1:1 디클로로메탄-헥산]로 2회 정제하여 무색 고체를 얻고, 이를 재결정하고(메탄올-에틸아세테이트×6), 진공 중에 건조시켰다 (P2O5, 1.0 mbar, 40℃, 48시간). 수율=0.77 g (66).Flash chromatography [fine mesh silica gel; 8 ethyl acetate-hexane and fine mesh silica gel; 1: 1 dichloromethane-hexane] twice to give a colorless solid, which was recrystallized (methanol-ethyl acetate × 6) and dried in vacuo (P 2 O 5 , 1.0 mbar, 40 ° C., 48 h). Yield = 0.77 g (66).
(S)-2-(4-펜톡시)부틸 4-(2',3'-디플루오로-4'-옥틸옥시비페닐-4-카르보닐옥시)-3-플루오로-벤조에이트 (34)(S) -2- (4-pentoxy) butyl 4- (2 ', 3'-difluoro-4'-octyloxybiphenyl-4-carbonyloxy) -3-fluoro-benzoate (34 )
플래쉬 크로마토그래피 [미세 메쉬 실리카겔; 헥산 중 10에틸아세테이트]로 정제하여 무색 겔을 얻었다. 이를 디클로로메탄에 재용해시키고, 밀리포어 필터를 통과시키고, 진공 중에 농축 및 건조시켰다 (P2O5, 1.0 mbar, 50℃, 18시간). 수율=0.74 g (57).Flash chromatography [fine mesh silica gel; 10 ethyl acetate in hexane] gave a colorless gel. It was redissolved in dichloromethane, passed through a Millipore filter, concentrated and dried in vacuo (P 2 O 5 , 1.0 mbar, 50 ° C., 18 h). Yield = 0.74 g (57).
반응식 6을 사용하여 하기 실시예 11에 기재된 화합물을 생성하였다.Scheme 6 was used to generate the compound described in Example 11 below.
<실시예 11><Example 11>
무수 및 2상 스즈끼 (Suzuki) 조건하에 팔라듐(0) 촉매화된 교차 커플링법을 사용하여 키랄 터페닐 액정 물질을 제조하였다. 1,2-디메톡시에탄 중에 아릴트리플레이트 및 아릴 붕산, 그리고 트리에틸아민 염기를 사용하여 무수 커플링을 수행하고, 아릴브로마이드 및 아릴 붕산 그리고 염기로서 탄산나트륨을 사용하여 스즈끼 커플링을 수행하였다 (상기 반응식 6 참조).A chiral terphenyl liquid crystal material was prepared using a palladium (0) catalyzed cross coupling method under anhydrous and biphasic Suzuki conditions. Anhydrous coupling was performed using aryltriplate and aryl boric acid, and triethylamine base in 1,2-dimethoxyethane, and Suzuki coupling was carried out using arylbromide and arylboric acid and sodium carbonate as base (above) See Scheme 6).
4'-(4-옥틸옥시페닐)페닐붕산 (36)4 '-(4-octyloxyphenyl) phenylboric acid (36)
건조 N2하에 -78℃에서 부틸리튬 2.0 ㎝3(약 20 밀리몰, 헥산 중 10.0M 용액)을 주사기를 통해 건조 테트라히드로푸란 150 ㎖ 중의 4-브로모-4'-옥틸옥시비페닐 (35) 6.05 g (16.8 밀리몰)의 교반된 혼합물에 적가하였다. 반응물을 -78℃에서 추가로 4시간 동안 교반되도록 방치하고, 건조 테트라히드로푸란 20 ㎖ 중의 트리메틸 붕산염 3.58 g (34.5 밀리몰)을 적가하여 열이 발생되지 않게 하였다. 혼합물을 -78℃에서 추가로 1.5시간 동안 교반한 후, 밤새 실온으로 가온되게 하였다. 10(v/v) 염산 50 ㎖를 적가하여 붕산 에스테르를 가수분해하였다. 혼합물을 추가로 0.5 시간 동안 교반한 후, 물 200 ㎖를 붓고, 디에틸에테르 3×70 ㎖를 사용하여 추출하였다. 한데모은 에테르 추출물을 MgSO4상에서 건조시키고, 여과하고, 증발시켜 왁스상 무색 고체를 얻고, 이를 진공하에 건조시켰다 (P2O5, 10 mbar, 실온, 72시간).Butyllithium 2.0 cm 3 (about 20 mmol, 10.0 M solution in hexane) at −78 ° C. under dry N 2 was injected via syringe into 4-bromo-4′-octyloxybiphenyl (35) in 150 ml of dry tetrahydrofuran. 6.05 g (16.8 mmol) was added dropwise to the stirred mixture. The reaction was left to stir at −78 ° C. for an additional 4 hours, and 3.58 g (34.5 mmol) of trimethyl borate in 20 ml of dry tetrahydrofuran were added dropwise to prevent heat generation. The mixture was stirred for an additional 1.5 h at -78 ° C and then allowed to warm to rt overnight. 50 ml of 10 (v / v) hydrochloric acid was added dropwise to hydrolyze the boric acid ester. The mixture was stirred for a further 0.5 h, then poured 200 ml of water and extracted with 3 × 70 ml of diethyl ether. Handemo ether ether extracts were dried over MgSO 4 , filtered and evaporated to give a waxy colorless solid which was dried under vacuum (P 2 O 5 , 10 mbar, room temperature, 72 h).
(S)-2-(4-펜톡시)부틸 4-(트리플루오로메틸술포닐옥시)벤조에이트 (37)(S) -2- (4-pentoxy) butyl 4- (trifluoromethylsulfonyloxy) benzoate (37)
트리플루오로메틸술폰산 무수물 3.35 g (11.9 밀리몰)을 건조 질소 하에 건조 피리딘 20 ㎖ 중의 화합물 7d 2.38 g (8.5 밀리몰)의 교반되고 0℃로 냉각된 혼합물에 적가하였다. 적가를 종결한 후, 반응물을 밤새 실온으로 가온되도록 방치하였다. 반응물을 물 200 ㎖에 붓고, 생성물을 디에틸에테르 5×50 ㎖를 사용하여 추출하였다. 한데모은 에테르상 추출물을 물 50 ㎖, 10염산 2×50 ㎖, 물 50 ㎖, 포화 염화나트륨 50 ㎖ 및 물 50 ㎖로 세척하고, MgSO4상에서 건조시키고, 진공하에 여과하고 증발시켜 연황색 액체를 얻었다. 플래쉬 크로마토그래피 [미세 메쉬 실리카겔; 헥산 중 10에틸아세테이트]로 정제하여 무색 액체를 얻었다. 진공하에 건조시켰다 (P2O5, 0.2 mbar, 실온, 18시간). 수율=3.02 g (84).3.35 g (11.9 mmol) of trifluoromethylsulfonic anhydride were added dropwise to a stirred and cooled mixture of 2.38 g (8.5 mmol) of compound 7d in 20 mL of dry pyridine under dry nitrogen. After completion of the dropwise addition, the reaction was allowed to warm to room temperature overnight. The reaction was poured into 200 mL of water and the product was extracted using 5 x 50 mL of diethyl ether. HANDemo silver ether phase extract was washed with 50 ml of water, 2 × 50 ml of 10 hydrochloric acid, 50 ml of water, 50 ml of saturated sodium chloride and 50 ml of water, dried over MgSO 4 , filtered under vacuum and evaporated to give a pale yellow liquid. . Flash chromatography [fine mesh silica gel; 10 ethyl acetate in hexane] gave a colorless liquid. Dry under vacuum (P 2 O 5 , 0.2 mbar, room temperature, 18 h). Yield = 3.02 g (84).
4-브로모-1-((S)-1-메틸-3-펜톡시프로폭시)벤젠 (39)4-Bromo-1-((S) -1-methyl-3-pentoxypropoxy) benzene (39)
건조 N2하에 실온에서 건조 테트라히드로푸란 10 ㎖ 중의 (R)-4-펜톡시부탄-3-올 (5d) 0.51 g (2.93 밀리몰), 트리페닐포스핀 0.51 g (1.94 밀리몰)을 건조 테트라히드로푸란 5 ㎖ 중의 디에틸 아조디카르복실레이트 0.35 g (2.01 밀리몰), 4-브로모페놀 (38) 0.34 g (1.96 밀리몰)의 용액에 적가하였다. 반응물을 실온에서 추가로 48시간 동안 교반한 후, 디에틸에테르 100 ㎖로 희석하고, 하이플로-수퍼셀 패드를 통해 여과하였다. 여액을 물 50 ㎖로 세척하고, MgSO4상에서 건조시키고, 진공하에 여과하고 증발시켜 무색 오일을 얻었다. 플래쉬 크로마토그래피 [미세 메쉬 실리카겔; 디클로로메탄]으로 정제하여 무색 오일을 얻고, 진공하에 건조시켰다 (P2O5, 10 mbar, 실온, 18시간). 수율=0.39 g (62).0.51 g (2.93 mmol) of (R) -4-pentoxybutan-3-ol (5d), 0.51 g (1.94 mmol) of triphenylphosphine in 10 mL of tetrahydrofuran dried at room temperature under dry N 2 To a solution of 0.35 g (2.01 mmol) of diethyl azodicarboxylate and 0.34 g (1.96 mmol) of 4-bromophenol (38) in 5 mL of furan was added dropwise. The reaction was stirred for an additional 48 hours at room temperature, then diluted with 100 mL of diethyl ether and filtered through a Hyflo-supercell pad. The filtrate was washed with 50 mL of water, dried over MgSO 4 , filtered under vacuum and evaporated to give a colorless oil. Flash chromatography [fine mesh silica gel; Dichloromethane] to give a colorless oil and dried under vacuum (P 2 O 5 , 10 mbar, room temperature, 18 h). Yield = 0.39 g (62).
(S)-2-(4''-옥틸옥시터페닐-4-카르보닐옥시)-1-펜톡시부탄 (40)(S) -2- (4 ''-octyloxyterphenyl-4-carbonyloxy) -1-pentoxybutane (40)
화합물 37 1.50 g (3.6 밀리몰), 화합물 36 1.28 g (3.9 밀리몰), 팔라듐(0) 테트라키스(트리페닐포스핀) 0.18 g (0.16 밀리몰), 염화리튬 0.47 g (11.1 밀리몰), 트리에틸아민 30 ㎖ 및 1,2-디메톡시에탄 30 ㎖를 건조 N2하에 5 시간 동안 온화하게 환류하에 가열하였다 (TLC 분석으로 잔류하는 출발물질이 나타나지 않음). 반응물을 디클로로메탄 150 ㎖로 희석하고, 하이플로-수퍼셀 패드를 통해 여과하고, 여액을 물 2×50 ㎖, 염수 50 ㎖로 세척하고, MgSO4상에서 건조시키고, 여과 및 증발시켜 연 황색 고체를 얻었다. 플래쉬 크로마토그래피 [미세 메쉬 실리카겔; 헥산 중 10에틸아세테이트 및 미세 메쉬 실리카겔; 1:1 디클로로메탄-헥산]으로 정제하여 무색 고체를 얻었다. 재결정(에탄올-에틸아세테이트×2)하고, 진공하에 건조시켰다(P2O5, 10 mbar, 50℃, 8시간). 수율=0.34 g (17).1.37 g (3.6 mmol) of compound 37, 1.28 g (3.9 mmol) of compound 36, 0.18 g (0.16 mmol) of palladium (0) tetrakis (triphenylphosphine), 0.47 g (11.1 mmol) of lithium chloride, triethylamine 30 ML and 30 mL of 1,2-dimethoxyethane were heated under mild reflux for 5 hours under dry N 2 (TLC analysis showed no starting material remaining). The reaction was diluted with 150 mL of dichloromethane, filtered through a pad of Hyflo-Supercell, the filtrate was washed with 2 x 50 mL of water, 50 mL of brine, dried over MgSO 4 , filtered and evaporated to give a pale yellow solid. Got it. Flash chromatography [fine mesh silica gel; 10 ethyl acetate and fine mesh silica gel in hexanes; 1: 1 dichloromethane-hexane] to give a colorless solid. Recrystallized (ethanol-ethyl acetate × 2) and dried under vacuum (P 2 O 5 , 10 mbar, 50 ° C., 8 hours). Yield = 0.34 g (17).
(S)-2-(4''-옥틸터페닐-4-옥시)-1-펜톡시부탄 (41)(S) -2- (4 ''-octylterphenyl-4-oxy) -1-pentoxybutane (41)
화합물 (36) 0.47 g (1.44 밀리몰), 화합물 (39) 0.36 g (1.14 밀리몰), 팔라듐(0) 테트라키스(트리페닐포스핀) 0.04 g (0.03 밀리몰), 2M 탄산나트륨 용액 8 ㎖ 및 1,2-디메톡시에탄 8 ㎖를 건조 N2하에 5시간 동안 교반하면서 온화하게 환류하에 가열하였다 (TLC 분석은 잔류하는 아릴브로마이드를 나타내지 않음). 반응물을 물 100 ㎖에 붓고, 생성물을 디에틸에테르 3×70 ㎖를 사용하여 추출하였다. 한데모은 에테르성 추출물을 염수 50 ㎖로 세척하고, MgSO4상에서 건조시키고, 여과하고 증발시켜 어두운 고체를 얻고, 이를 디클로로메탄을 사용하는 짧은 실리카겔 컬럼을 통과시켜 기저 물질을 제거하였다. 플래쉬 크로마토그래피로 연한 고체를 정제하여 [미세 메쉬 실리카겔; 1:1 디클로로메탄-헥산, 이어서 미세 메쉬 실리카겔; 9:1 디클로로메탄-헥산] 무색 고체를 얻었다. 재결정하고 (톨루엔×3), 진공하에 건조시켰다 (P2O5, 10 mbar, 50℃, 8시간). 수율=0.16 g (27).0.47 g (1.44 mmol) of compound (36), 0.36 g (1.14 mmol) of compound (39), 0.04 g (0.03 mmol) of palladium (0) tetrakis (triphenylphosphine), 8 mL of 2M sodium carbonate solution and 1,2 8 ml of dimethoxyethane was heated under gentle reflux with stirring for 5 h under dry N 2 (TLC analysis did not show residual arylbromide). The reaction was poured into 100 mL of water and the product was extracted using 3 x 70 mL of diethyl ether. HANDemo silver ether extract was washed with 50 ml brine, dried over MgSO 4 , filtered and evaporated to give a dark solid which was passed through a short silica gel column with dichloromethane to remove the base material. Purification of the pale solid by flash chromatography [Fine mesh silica gel; 1: 1 dichloromethane-hexane, followed by fine mesh silica gel; 9: 1 dichloromethane-hexane] to give a colorless solid. Recrystallized (toluene × 3) and dried under vacuum (P 2 O 5 , 10 mbar, 50 ° C., 8 hours). Yield = 0.16 g (27).
목적하는 화합물 및 중간체의 광학 순도를 확인하기 위하여, 2가지 방법, (1) NMR 및 키랄 이동 시약 방법의 사용 및 (2) 분석 장치 (즉, NMR, GC 또는 HPLC)에 의해 정량화될 수 있는 유도화에 의한 디아스테레오 이소머 혼합물의 형성을 사용하였다.In order to confirm the optical purity of the desired compounds and intermediates, two methods, (1) the use of NMR and chiral transfer reagent methods, and (2) derivatization that can be quantified by analytical devices (ie, NMR, GC or HPLC) The formation of diastereo isomer mixtures by means of was used.
방법 (1)-직접 NMR 및 키랄 이동 시약 방법Method (1)-Direct NMR and Chiral Transfer Reagent Methods
메틸-3-히드록시부티레이트의 라세미체 (R,S)-시료를 사용한 점을 제외하고는, 반응식 2에 기재된 바와 같이 (S)-에난티오머 (화합물 8d)의 합성에서 기재된 바와 동일한 순서의 반응을 사용하여 (S)-2-(4-펜톡시)부틸 4-(4'-도데실옥시비페닐-4-카르보닐옥시)벤조에이트 (42)의 라세미체 변형물을 제조하였다. 이 물질은1H NMR 및 키랄 쉬프트 시약인 유로피움 트리스(D-3-플루오로아세틸캄포레이트)를 사용하여 (S)-에난티오머의 광학 순도를 결정하는데 사용되었다. 그러나, NMR 시약에 쉬프트 시약을 증가시켜 첨가하는 것은 방향족 수소 신호의 라인 광폭을 초래하였다.Same procedure as described in the synthesis of (S) -enantiomer (Compound 8d) as described in Scheme 2, except that a racemate (R, S) -sample of methyl-3-hydroxybutyrate was used. The racemic variant of (S) -2- (4-pentoxy) butyl 4- (4'-dodecyloxybiphenyl-4-carbonyloxy) benzoate (42) was prepared using the reaction of. This material was used to determine the optical purity of (S) -enantiomer using 1 H NMR and chiral shift reagent Europium Tris (D-3-fluoroacetylcamphorate). However, increasing the shift reagent to the NMR reagent resulted in a line width of the aromatic hydrogen signal.
방법 (2)- 모쉐르(Mosher)의 에스테르에 의한 화학적 유도화Method (2)-chemical derivatization with esters of Mosher
(S)-2-(4-펜톡시)부틸 4-히드록시벤조에이트의 (R)-모쉐르 에스테르 (44)(R) -Mosher ester of (S) -2- (4-pentoxy) butyl 4-hydroxybenzoate (44)
(R)-(-)-α-메톡시-(트리플루오로메틸)페닐아세틸클로라이드 100 ㎎을 주사기/격막을 통해 (S)-2-(4-펜톡시)부틸 4-히드록시벤조에이트 (7d) 0.06 g 및 건조 트리에틸아민 0.5 ㎖를 함유하는 바이알로 주입하였다. 황색 용액은 즉시 혼탁해지고, 염산염이 침전화되면서 '겔화'되었다. 반응물을 60℃로 추가로 2시간 동안 가온시키고, 물 1 ㎖ 및 10(v/v) 염산 1 ㎖로 켄칭시켰다. 생성물을 디클로로메탄 4×0.5 ㎖를 사용하여 추출하였다. 유기 용액을 농축한 후, 컬럼 크로마토그래피[실리카겔;디클로로메탄]로 정제하였고, 생성물 (Rf=0.21(CH2Cl2))을 16개의 분획물에서 수거하고, 진공하에 농축하고 건조시켰다 (P2O5, 10mbar,실온, 3 시간).100 mg of (R)-(-)-α-methoxy- (trifluoromethyl) phenylacetylchloride was injected via syringe / diaphragm into (S) -2- (4-pentoxy) butyl 4-hydroxybenzoate ( 7d) injected into a vial containing 0.06 g and 0.5 ml of dry triethylamine. The yellow solution immediately became turbid and 'gelled' as the hydrochloride precipitated. The reaction was warmed to 60 ° C. for another 2 hours and quenched with 1 ml of water and 1 ml of 10 (v / v) hydrochloric acid. The product was extracted using 4 x 0.5 mL of dichloromethane. The organic solution was concentrated and then purified by column chromatography [silica gel; dichloromethane] and the product (Rf = 0.21 (CH 2 Cl 2 )) was collected from 16 fractions, concentrated in vacuo and dried (P 2 O). 5 , 10 mbar, room temperature, 3 hours).
커플링은 HH 코지 (COSY) 분광기로 확인하였다.Coupling was confirmed by HH Cozy (COSY) spectroscopy.
라세미체 모쉐르의 에스테르 혼합물 (45)의 시료를 제조하기 위한 방법과 유사하게 (R,S)-2-(4-펜톡시)부틸 4-히드록시벤조에이트 (43, 화합물 42의 합성을 위해 제조됨)을 사용하였고, 그의 NMR 스펙트럼은 화합물 44에 대해 기재된 바와 동일하였다.The synthesis of (R, S) -2- (4-pentoxy) butyl 4-hydroxybenzoate (43, compound 42) was analogous to the method for preparing a sample of the ester mixture of racemic mosher (45). Prepared for) and its NMR spectrum was the same as described for compound 44.
화합물 44가 광학적으로 순수하다는 가정하에, 주요 생성물은 소량의 (R), (R)-디아스테레오머가 또한 존재하는, (R)-,(S)-디아스테레오 이소머일 것이다. 이와같이 화합물 45는 동량의 (R)-,(R)-모쉐르 에스테르 디아스테레오 이소머 및 (R)-,(S)-모쉐르 에스테르 디아스테레오 이소머를 포함하는 것으로 기대될 수 있다. 이러한 물질의 분석은 이를 확인시켜 줄 것이다. 처음에는,19F NMR을 사용하여 2가지 물질의 광학 순도를 측정하였으나, CF3신호 (약 72 ppm)의 해상은 '라세미체' 또는 '에난티오머'에 관해서 관찰되지 않았다 (화합물 44 및 45 각각에 대해서). 유사하게, GC는 GC 주입 조건 (220-280℃)하에 화합물의 낮은 휘발성 때문에, 상이한 디아스테레오 이소머를 분리하는데 실패하였다. 그러나, 97:3 헥산:2-프로판올 용매 혼합물을 사용하는 실리카겔 컬럼 상의 시료의 HPLC는 화합물 44가 7.43분의 체류 시간을 갖는 하나의 디아스테레오 이소머(즉, (S)-2-(4-펜톡시)부틸 4-히드록시벤조에이트 (7d) 및 모든 최종 액정물질은 광학적으로 순수함)라는 것을 나타내었다. 화합물 45를 체류시간이 각각 6.97분 및 7.33분인 (R),(R) 및 (R),(S) 디아스테레오 이소머로 분리되었다.Under the assumption that compound 44 is optically pure, the main product will be (R)-, (S) -diastereo isomer, in which a small amount of (R), (R) -diastereomer is also present. As such Compound 45 can be expected to include the same amount of (R)-, (R) -Mosher ester diastereo isomer and (R)-, (S) -Mosher ester diastereo isomer. Analysis of these substances will confirm this. Initially, the optical purity of the two materials was measured using 19 F NMR, but no resolution of the CF 3 signal (about 72 ppm) was observed with respect to 'racemate' or 'enantiomer' (compounds 44 and 45 each). Similarly, GC failed to separate different diastereo isomers due to the low volatility of the compound under GC injection conditions (220-280 ° C.). However, HPLC of a sample on a silica gel column using a 97: 3 hexanes: 2-propanol solvent mixture showed that one diastereo isomer (ie, (S) -2- (4-) has a retention time of 7.43 minutes. Pentoxy) butyl 4-hydroxybenzoate (7d) and all final liquid crystal materials are optically pure). Compound 45 was isolated with (R), (R) and (R) and (S) diastereo isomers with retention times of 6.97 and 7.33 minutes, respectively.
화합물 26-30, 32-34 및 40-42의 전이 온도 및 상 거동을 광학 현미경 및 시차 주사 열량계의 조합을 사용하여 측정하였고, 결과를 하기 표 3에 나열하였다.The transition temperatures and phase behaviors of compounds 26-30, 32-34 and 40-42 were measured using a combination of optical microscopy and differential scanning calorimetry, and the results are listed in Table 3 below.
<전기-광학 결과>Electro-optical results
2-3 ㎛ 두께의 반대로 평행하게 배열된 ITO 코팅된 전지를 등방성 상의 각 물질로 충진시키고, 서서히 실온으로 냉각되도록 방치하였다. 전극을 ITO에 부착시키고, 전지를 교차된 분극제 사이에 위치시켰다. 몇몇 온도에서 전압에 대한 원뿔각 θ, 자발 분극 PS및 온 (τ온) 및 오프 (τ오프) 반응 시간을 측정하였다.τ온은 어두운 (오프) 상태에서 90 의 밝은 상태 사이를 스위칭하여 얻은 시간 (즉, T0-T90)인 것으로 정의되며, τ오프는 가장 밝은 (온) 상태에서 10 의 어두운 상태 사이에 스위칭한 시간 (즉, T100-T10)으로 얻어진다.ITO coated cells arranged in parallel in parallel with a thickness of 2-3 μm were filled with each material of the isotropic phase and left to cool slowly to room temperature. The electrode was attached to ITO and the cell was placed between crossed polarizers. The cone angle θ, the spontaneous polarization P S, and the on (τ on) and off (τ off) reaction times for voltage at several temperatures were measured. [Tau] was obtained by switching between 90 bright states in the dark (off) state. Defined as being time (ie, T 0 -T 90 ), τ off is obtained by switching time between the brightest (on) state and the dark state of 10 (ie, T 100 -T 10 ).
(S)-2-(알콕시)부틸 4-(4'-도데실옥시비페닐-4-일카르보닐옥시)벤조에이트 (8a 내지 8f)의 융점은 모두 실온 이상 (59.4-69.4 ℃, 상기 표 1 참조)이며, 따라서 다른 물질과의 혼합물로 사용하여 융점을 감소시켜야 한다. 적절한 특성 (원뿔각, 스위칭 속도 및 자발인 분극)를 하기 표 4에 나열하였다.The melting points of (S) -2- (alkoxy) butyl 4- (4'-dodecyloxybiphenyl-4-ylcarbonyloxy) benzoate (8a to 8f) are all room temperature or higher (59.4-69.4 ° C, Table 1 above). Therefore, the melting point should be reduced by using it as a mixture with other materials. Appropriate properties (cone angle, switching speed and spontaneous polarization) are listed in Table 4 below.
화합물 8a 내지 8d 및 화합물 8e 및 8f의 온도에 대한 원뿔각의 의존성을 도 1 및 도 2에 각각 나타냈다. 대부분의 소자 응용의 경우, 최대 밝음은 원뿔각이 45˚일 때 얻어지고, 즉 디렉터가 분극제 중 하나와 함께 배열될 때 가장 어두운 상태 (일반적으로 0 V 상태)가 얻어지고, 디렉터가 각 분극제에 대해 45˚로 배열될 때 가장 밝은 상태가 얻어졌다. 따라서, 이상적으로는 원뿔각은 최적 효율을달성하기 위해 가능한 한 45˚에 가까워야 한다. 달성가능한 30˚의 원뿔각은 sin2(2θ) 관계에 따르며, 예를 들어 0.7의 휘도에 상응하고, 35˚의 원뿔각은 약 0.9의 휘도에 상응한다. 그러나, 다른 소자 기하학은 최대 원뿔각이 45˚ 미만인 경우 이용될 수 있다.The dependence of the cone angle on the temperatures of compounds 8a-8d and compounds 8e and 8f is shown in FIGS. 1 and 2, respectively. For most device applications, maximum brightness is obtained when the cone angle is 45 °, i.e. the darkest state (typically 0 V state) is obtained when the director is arranged with one of the polarizers, and the director has each polarization The brightest state was obtained when arranged at 45 ° with respect to wood. Ideally, the cone angle should be as close to 45 ° as possible to achieve optimum efficiency. Achievable cone angles of 30 [deg.] Correspond to the sin 2 ( 2 [theta]) relationship, for example correspond to a luminance of 0.7 and cone angles of 35 [deg.] Correspond to a luminance of about 0.9. However, other device geometries can be used when the maximum cone angle is less than 45 °.
상기 물질들의 상은 불적절하지만, 화합물 8a-d의 원뿔각은 약 30-35˚ 범위이고, 0.9 투과의 가능성을 제공하였다. τ온은 모두 대부분의 소자의 경우 적절한 ms 이하이었다. 그러나, τ오프는 상당히 길었다. 그러나, 이들 측정은 70 ℃에서 행하였고, 점성으로 인해 이들은 실온에서 상당히 길었다.The phases of these materials are inadequate, but the cone angles of compounds 8a-d range from about 30-35 °, providing the possibility of 0.9 transmission. All the τ temperatures were below the appropriate ms for most devices. However, τ off was quite long. However, these measurements were taken at 70 ° C. and due to the viscosity they were quite long at room temperature.
(S)-2-(4-펜톡시)부틸 4-(4'-도데실옥시-모노플루오로-비페닐-4-일카르보닐옥시)벤조에이트 (26-30)(S) -2- (4-pentoxy) butyl 4- (4'-dodecyloxy-monofluoro-biphenyl-4-ylcarbonyloxy) benzoate (26-30)
융점 및 상 전이 온도를 낮추기 위해, 불소 원자를 하기 화학식 113의 비페닐 코어의 a, b, c 또는 d 위치의 각각에 치환시켰다.To lower the melting point and phase transition temperature, a fluorine atom was substituted at each of the a, b, c or d positions of the biphenyl core of formula 113 below.
상 전이는 표 3에 나타냈다. 코어의 임의 위치에 불소 원자의 첨가는 융점 및 상 전이를 낮추는 효과를 가졌다. 그러나, 값들은 실온 이상이지만, 혼합물의 성분으로 사용하기 위한 후보자이다. 상기 측정은 29번을 제외한 화합물의 융점이하인 40 ℃에서 행하였다. 물질을 초냉각시켜 융점 이하의 온도에서 측정을 상당히 용이하게 하였다. 일반적인 경향은 F가 고리의 내측 (b 또는 c 위치)에 있는 화합물의 원뿔각은 F가 고리의 외측 (a 또는 d 위치)에 있는 화합물 보다 매우 낮았다. 최대 원뿔각이 온도 차이가 40 ℃가 되지 않도록 하기 위해 그리고 또한 온도 변화에 따른 실제 틸트각을 조사하기 위해, θ를 전체 기울어진 상 범위에 걸쳐 측정하였다. 이것은 θ를 화합물 26 및 120의 경우 약 ±31˚로 감소시켰고, 27 및 101의 경우는 하기 나열되고 플롯된 바와 같이 감소시켰다. 그러나, F가 고리의 내측 위치에 있는 경우 원뿔각이 상당히 작은 경향이 있었다. 전기-광학 측정은 하기 표 5에 결과를 나타냈다.Phase transitions are shown in Table 3. The addition of fluorine atoms anywhere in the core had the effect of lowering the melting point and phase transition. However, the values are above room temperature but are candidates for use as components of the mixture. The measurement was performed at 40 ° C. below the melting point of the compound except for No. 29. The material was supercooled to facilitate measurement at temperatures below the melting point. The general trend is that the cone angle of the compound where F is inside the ring (b or c position) is much lower than the compound where F is outside the ring (a or d position). To determine the maximum cone angle so that the temperature difference does not reach 40 ° C. and also to investigate the actual tilt angle with temperature change, θ was measured over the entire tilted phase range. This reduced θ to about ± 31 ° for compounds 26 and 120 and for 27 and 101 as listed and plotted below. However, when F was in the inner position of the ring, the cone angle tended to be quite small. Electro-optical measurements are shown in Table 5 below.
도 3은 4개의 상이한 플루오로 치환 패턴의 경우 온도에 따른 틸트의 의존성을 보여준다. 화합물 26 내지 29에 대한 최대 원뿔각 및 적절한 온도 범위를 하기 표 6에 나열하였다.3 shows the dependence of tilt on temperature for four different fluoro substitution patterns. The maximum cone angles and appropriate temperature ranges for compounds 26 to 29 are listed in Table 6 below.
상기 물질의 상은 이상적이지 않지만, 화합물 26 및 29의 원뿔각 (약 ±30˚)은 0.75의 투과의 가능성을 제공하였다. 플루오르화되지 않은 시리즈의 경우, τ온은 모두 대부분의 소자의 경우 적절한 ms 이하이고, τ오프는 상당히 길었다. 그러나, 이들 측정은 40 ℃에서 행하였고, 점성으로 인해 이들은 실온에서 상당히 길었다.The phase of the material is not ideal, but the cone angles (about ± 30 °) of compounds 26 and 29 provided the possibility of transmission of 0.75. For the non-fluorinated series, τ ions were all below the appropriate ms for most devices, and τ off was quite long. However, these measurements were made at 40 ° C. and due to the viscosity they were quite long at room temperature.
상 범위 및 반응 시간은 플루오르화되지 않은 시리즈에 대해 개선되었고, 혼합물의 경우 성분들로서 가능성이 개선되었다.Phase range and reaction time were improved for the non-fluorinated series, and in the case of mixtures, the possibilities were improved as components.
(S)-2-(펜톡시)부틸 4-(4'-알콕시-폴리플루오로-치환된-비페닐-4-일카르보닐옥시)벤조에이트 및 3-플루오로-벤조에이트 (32, 33 및 34)(S) -2- (pentoxy) butyl 4- (4'-alkoxy-polyfluoro-substituted-biphenyl-4-ylcarbonyloxy) benzoate and 3-fluoro-benzoate (32, 33 And 34)
상 전이를 더 감소시키기 위해, 2 또는 3개의 불소 원자를 상기 화학식에 나타낸 위치에서 코어의 고리에 치환시켰다. 상 전이는 표 3에 나열되어 있다. a및 b, 및 a, b 및 c 위치에 각각 치환체를 갖는 화합물 32 및 34는 완전히 기울어진 상을 손실하였다 (즉, 단지 SA만 가졌다). 화합물 26과 화합물 33의 비교는 제3 고리의 e 위치에 F의 첨가는 융점을 약 12 ℃ 만큼 감소시켰고, I - SA전이를 약 40˚ 만큼 감소시켰다. 50 ℃에서 측정한 결과를 하기 표 7에 제공하였다.To further reduce the phase transition, two or three fluorine atoms were substituted for the ring of the core at the position shown in the above formula. Phase transitions are listed in Table 3. Compounds 32 and 34, having a and b, and substituents at positions a, b, and c, respectively, lost a completely tilted phase (ie, only had S A ). Comparison of compound 26 and compound 33 showed that the addition of F to the e position of the third ring reduced the melting point by about 12 ° C. and reduced the I-S A transition by about 40 °. The results measured at 50 ° C. are provided in Table 7 below.
최대 θ는 1.6 V에서 얻었다. θ 대 온도의 측정을 기록하였다. 틸트각 0만이 45 ℃에서 ±30.5˚로 매우 약간 증가시켰고 도 4에 보여준다.The maximum θ was obtained at 1.6 V. The measurement of θ vs. temperature was recorded. Only tilt angle 0 increased very slightly from 45 ° C. to ± 30.5 ° and is shown in FIG. 4.
원래 플루오로 비치환된 물질 시리즈 (화합물 8a - 8f)에서 상이한 사슬 길이의 화합물의 혼합 (8e (n = 12) 및 8d (n = 5) 1:1)은 유사한 융점을 갖는 혼합물을 생성하였다. SA- Iso 및 SC* - SA전이는 2성분 사이의 거의 중간이었고, 결정화 점은 소량만으로 낮추었다. 화합물 8d (n = 5)와 화합물 29 (d = F, n = 5)의 혼합은 2성분 사이의 중간 특성을 갖는 혼합물을 생성하였다. 디/트리 플루오로 치환된 시리즈의 혼합은 실온 작동 및 소자에 사용될 수 있는 적절한 스위칭 각을 갖는 혼합물을 생성하였다. 화합물 33, 32 및 34의 혼합물 (75:10:15 비율)은광학 현미경 및 DSC에 의해 특징지워지는 바와 같은 하기 상을 제공하였다 (하기 표 8 참조).In the original series of fluoro unsubstituted materials (compounds 8a-8f), mixing of compounds of different chain lengths (8e (n = 12) and 8d (n = 5) 1: 1) yielded mixtures with similar melting points. The S A -Iso and S C *-S A transitions were nearly intermediate between the two components and the crystallization point was lowered only in small amounts. Mixing of compound 8d (n = 5) and compound 29 (d = F, n = 5) yielded a mixture with intermediate properties between the two components. Mixing of the di / tri fluoro substituted series produced a mixture with the appropriate switching angles that could be used for room temperature operation and devices. Mixtures of compounds 33, 32 and 34 (75:10:15 ratio) gave the following phases as characterized by optical microscopy and DSC (see Table 8 below).
상기 3성분 혼합물의 원뿔각 대 전압 특성을 기록하였고 (도 5), ±27.5˚의 최대 원뿔각을 약 3.6 V에서 얻었다.The cone angle versus voltage characteristics of the three-component mixture were recorded (FIG. 5) and a maximum cone angle of ± 27.5 ° was obtained at about 3.6 V.
요약하면, 75:10:15 비의 디/트리 플루오로 치환된 화합물 (33, 32 및 34)의 혼합은 ±27.5˚ (0.67의 최대 이론적 투과에 상응)의 원뿔각을 갖는 실온 스위칭을 제공하는 혼합물을 생성하였다.In summary, the mixing of di / trifluoro substituted compounds 33, 32 and 34 in a 75:10:15 ratio provides room temperature switching with a cone angle of ± 27.5 ° (corresponding to a maximum theoretical transmission of 0.67). A mixture was produced.
도 6은 능동 매트릭스 어레이를 포함하는 액정 소자에서 전형적인 전지의 구조를 보여준다. 한쌍의 투과성 기판 (유리 또는 중합체 플레이트) (2) 및 (4)를 이들 사이의 간격 (6)에 거의 평행하게 배열시켰다. 플레이트 (2) 및 (4)를 소자의 최대 어두운 상태가 0 볼트의 인가된 전압에서 얻어지도록 배열된 교차된 분극제 (도시되지 않음) 사이에 배치시켰다. 각각의 투과성 기판 (2) 및 (4)의 대향 표면 (2a) 및 (4a)를 각각 투과성 전극 (8)과 함께 제공하였고, 배열층 (예를 들어, 유기 또는 무기 박막) (9)을 각 전극 (8) 위에 제공하였다. 간격 (6)은 본 발명에 따른 액정 조성물을 함유하였다.6 shows the structure of a typical cell in a liquid crystal device comprising an active matrix array. A pair of permeable substrates (glass or polymer plates) 2 and 4 were arranged almost parallel to the gap 6 between them. Plates 2 and 4 were placed between crossed polarizers (not shown) arranged such that the maximum dark state of the device was obtained at an applied voltage of 0 volts. Opposing surfaces 2a and 4a of each transmissive substrate 2 and 4 were provided with a transmissive electrode 8, respectively, and an array layer (e.g., organic or inorganic thin film) 9 was provided for each It was provided over the electrode 8. The interval 6 contained the liquid crystal composition according to the present invention.
소자를 위해 어드레싱 도식을 실행하기 위해 도 7a 및 7b에 보여주는 쌍극 스위칭 파형의 각각의 서브프레임 동안 거의 일정한 전압을 액정 물질을 가로질러 인가하였다. 이러한 전압의 인가는 2가지 상이한 방식으로 달성될 수 있다. 도 8에 보여주는 제1 실시태양에서, 화소의 정사각형 능동 매트릭스 어레이 (10)는 데이타 드라이버 (12)에 의해 어드레싱된 세로 전극 및 주사 드라이버 (14)에 의해 어드레싱된 가로 전극을 포함하고, 각 화소와 연결된 능동 회로 (16)는 주사 전극 (20)에 그의 게이트에 의해 연결되고 데이타 전극 (22)에 그의 드레인에 의해 연결된 폴리실리콘 박막 필트 이펙트 트랜지스터 (18), 콘덴서 (26)과 평행한 트랜지스터 (18)의 공급원에 연결된 고정 저장 축전기 (24)를 포함한다. 전극 (20)이 주사 드라이버 (14)로부터 주사 펄스를 받을 때, 트랜지스터 (18)는 데이타 전극 (22) 위의 전압이 데이타 드라이버 (12)에 의해 인가되도록 켜져 저장 축전기 (24)를 충전시켰다. 주사 펄스가 주사 전극 (20)으로부터 제거될 때, 트랜지스터 (18)은 데이타 전극 (22)으로부터 저장 축전기 (24)를 분리하기 위해 꺼져 화소의 광투과는 다음 프레임 동안 재충전될 때까지 저장 축전기 (24)에 걸친 전압에 상응한다. 사용되는 액정 방식의 자발인 분극이 높기 때문에, 다량의 전하를 화소에 인가하는 것이 필요하고, 따라서 큰 저장 축전기 (24)는 거의 일정한 전압에서 전하 이동을 수행하는데 필요하다. 그러나, 전하는 주사 라인 기간내에 이동되어야 하고, 이것은 흐르는 상당한 피크 전류가 필요하여 상당한 전력을 소모시킨다. 더욱이, 큰저장 축전기는 디스플레이의 개구 비율에 악영향을 미친다.An almost constant voltage was applied across the liquid crystal material during each subframe of the dipole switching waveform shown in FIGS. 7A and 7B to implement the addressing scheme for the device. The application of this voltage can be accomplished in two different ways. In the first embodiment shown in FIG. 8, the square active matrix array 10 of pixels comprises a vertical electrode addressed by the data driver 12 and a horizontal electrode addressed by the scan driver 14, each pixel having The connected active circuit 16 is connected to the scan electrode 20 by its gate and parallel to the polysilicon thin film filter effect transistor 18, the capacitor 26, connected by its drain to the data electrode 22. A fixed storage capacitor 24 connected to a source of power. When the electrode 20 receives a scan pulse from the scan driver 14, the transistor 18 is turned on so that the voltage on the data electrode 22 is applied by the data driver 12 to charge the storage capacitor 24. When the scan pulse is removed from the scan electrode 20, the transistor 18 is turned off to separate the storage capacitor 24 from the data electrode 22 so that the light transmission of the pixel is recharged for the next frame. Corresponds to the voltage across. Since the polarization, which is a spontaneous spontaneous liquid crystal method, is high, it is necessary to apply a large amount of charge to the pixel, and therefore a large storage capacitor 24 is necessary to perform charge transfer at an almost constant voltage. However, the charge must be moved within the scan line period, which requires a significant peak current to flow and consumes significant power. Moreover, large storage capacitors adversely affect the aperture ratio of the display.
본 발명의 소자에 사용하기 위한 변형 능동 회로 (16')는 도 9에서 보여지며, 이미 언급된 성분 이외에 완충 증폭기 (28)는 매우 높은 입력 임피던스 및 비교적 낮은 출력 임피던스를 가지므로, 트랜지스터 (18)은 꺼지고, 증폭기 (28)의 출력은 저장 축전기에 걸친 전압을 따르는 반면, 증폭기 (28)의 입력에 공급된 전류는 무시할 수 있어 저장 축전기 (24)의 방전이 이전 회로 배열에서 보다 매우 느리다. 따라서, 저장 축전기 (24)는 트랜지스터 (18)가 켜져 있을 때 소정의 전압 이하로 용이하게 대전될 수 있는 비교적 작은 축전기일 수 있다. 증폭기 (28)의 출력에 연결된 화소는 저장 축전기 (24)의 전압과 동일한 일정한 전압을 받으며, 전하는 액정 물질이 스위칭되는 속도로 공급되기 때문에 회로는 전술한 능동 회로 보다 동력 전력을 적게 소비한다. 완충 증폭기는 또한 어드레싱 도식에서 필요한 서브프레임 반전을 실행하여 반복가능한 그레이 수준을 달성할 수 있다.A variant active circuit 16 ′ for use in the device of the present invention is shown in FIG. 9, and in addition to the components already mentioned, the buffer amplifier 28 has a very high input impedance and a relatively low output impedance, so that the transistor 18 Is turned off and the output of the amplifier 28 follows the voltage across the storage capacitor, while the current supplied to the input of the amplifier 28 is negligible so that the discharge of the storage capacitor 24 is much slower than in the previous circuit arrangement. Thus, storage capacitor 24 may be a relatively small capacitor that can easily be charged below a predetermined voltage when transistor 18 is on. The pixel connected to the output of the amplifier 28 receives a constant voltage equal to the voltage of the storage capacitor 24, and since the electric charge is supplied at a rate at which the liquid crystal material is switched, the circuit consumes less power than the active circuit described above. The buffer amplifier can also perform the necessary subframe inversion in the addressing scheme to achieve repeatable gray levels.
본 발명의 방법에 따르면 광범위한 반강유전성 SA상, 낮은 스위칭 시간, 전압 및 분극 계수를 나타내는 화합물 및 조성물, 및 그를 포함하는 액정 소자를 얻을 수 있다.According to the method of the present invention, compounds and compositions exhibiting a wide range of antiferroelectric S A phases, low switching times, voltages and polarization coefficients, and liquid crystal devices including the same can be obtained.
Claims (44)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9814450.4 | 1998-07-04 | ||
GBGB9814450.4A GB9814450D0 (en) | 1998-07-04 | 1998-07-04 | Novel compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20000011465A KR20000011465A (en) | 2000-02-25 |
KR100314366B1 true KR100314366B1 (en) | 2001-11-15 |
Family
ID=10834904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019990026751A KR100314366B1 (en) | 1998-07-04 | 1999-07-03 | Antiferroelectric Liquid Crystal Display Device and Antiferroelectric compounds and Compositions for Use Therein |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP3835661B2 (en) |
KR (1) | KR100314366B1 (en) |
GB (1) | GB9814450D0 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2362882A (en) * | 2000-06-02 | 2001-12-05 | Sharp Kk | Liquid crystalline optionally laterally fluorinated terphenyl with chiral 3,4-di[(un)saturated-alkoxy]butoxy or 1,4-di[(un)saturated-alkoxy]but-2-oxy terminus |
JO3598B1 (en) | 2006-10-10 | 2020-07-05 | Infinity Discovery Inc | Boronic acids and esters as inhibitors of fatty acid amide hydrolase |
WO2009126691A1 (en) | 2008-04-09 | 2009-10-15 | Infinity Pharmaceuticals, Inc | Inhibitors of fatty acid amide hydrolase |
AU2010234445A1 (en) | 2009-04-07 | 2011-11-03 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
AU2010234449A1 (en) | 2009-04-07 | 2011-11-03 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
JP2013518886A (en) | 2010-02-03 | 2013-05-23 | インフイニトイ プハルマセウトイカルス インコーポレイテッド | Fatty acid amide hydrolase inhibitor |
-
1998
- 1998-07-04 GB GBGB9814450.4A patent/GB9814450D0/en not_active Ceased
-
1999
- 1999-07-02 JP JP18979999A patent/JP3835661B2/en not_active Expired - Fee Related
- 1999-07-03 KR KR1019990026751A patent/KR100314366B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP3835661B2 (en) | 2006-10-18 |
KR20000011465A (en) | 2000-02-25 |
GB9814450D0 (en) | 1998-09-02 |
JP2000035596A (en) | 2000-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5938973A (en) | Swallow-tailed compound and ferrielectric liquid crystal composition containing the same | |
WO2010012994A1 (en) | Liquid crystal compounds | |
KR100314366B1 (en) | Antiferroelectric Liquid Crystal Display Device and Antiferroelectric compounds and Compositions for Use Therein | |
US5202054A (en) | Liquid crystal compound | |
US5951914A (en) | Racemic compound and anti-ferroelectric liquid crystal composition | |
JPH10279534A (en) | Racemic compound and antiferroelectric liquid crystal composition containing the same | |
EP0586263B1 (en) | A liquid crystal compound | |
WO2015009290A1 (en) | Birefringence improving agent, ferroelectric liquid crystal composition and liquid crystal display device using the agent, and compound | |
TWI691483B (en) | Chiral dopants having a nortricyclan unit | |
US6007739A (en) | Liquid crystal compound, liquid crystal composition, and liquid crystal display device using the same | |
KR980010491A (en) | Optically active compound, Liquid crystal composition containing this optically active compound, And liquid crystal display element | |
US5853612A (en) | Compound for use in liquid crystal composition, liquid crystal composition comprising the same, and liquid crystal display device using the same | |
JP4562239B2 (en) | Phenylacetylene compound, liquid crystal material, liquid crystal composition, and liquid crystal element | |
JPH04282345A (en) | Optically active compound | |
JP2989317B2 (en) | Liquid crystal compositions containing novel phenylpyridine compounds | |
JP3819460B2 (en) | Antiferroelectric liquid crystal compound and antiferroelectric liquid crystal composition | |
JP2014214137A (en) | Compound, ferroelectric liquid crystal composition using the same and liquid crystal display element | |
KR20000028981A (en) | Novel phenyl triester compound and anti-ferroelectric liquid crystal composition containing the same | |
JP4438106B2 (en) | Fluorinated biphenyl compound, liquid crystal material or composition, and liquid crystal element | |
JPH04261162A (en) | Optically active pyrazine compound and display element | |
JP2966140B2 (en) | Novel cyclohexanecarboxylic acid ester compound and liquid crystal composition containing the same | |
KR20000011871A (en) | Ferrielectric liquid crystal compound | |
JPH04368370A (en) | New phenylquinoline compound, liquid crystal composition and optical switching element containing the same | |
KR20010022268A (en) | Fluorine-substituted compounds and ferrielectric liquid-crystal composition containing the same | |
JPH04342547A (en) | Optically active compound and displaying element |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20081024 Year of fee payment: 8 |
|
LAPS | Lapse due to unpaid annual fee |